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Abstract 
Sequence analytical tools can provide predictions of aspects of protein function such as 
enzymatic activities or sites of posttranslational modifications in protein sequences. 
Generally, an experimental verification is needed for these predictions. In the case of lipid 
posttranslational modifications, the standard experimental techniques are time-consuming 
and laborious. In this work, a new in vitro assay based upon the detection of incorporation 
of radioactively labeled lipid anchor precursors into in vitro translated proteins with a thin 
layer chromatography scanner was developed. This method drastically reduces time effort, 
it combines protein yield and anchor incorporation testing in a single experiment, and it is 
both applicable for prenylation and myristoylation. This assay has been used for 
investigation of prenylation and myristoylation of selected candidate proteins. Localization 
studies with GFP fusion proteins were used to verify the in vivo relevance of the results. 
The general potential of prenylation motifs in bacterial proteins to be modified by 
eukaryotic prenyltransferases was demonstrated in vitro for a so far uncharacterized, 
ankyrin repeat containing protein from Coxiella burnetii. The localization studies also 
suggest prenylation of an F-Box containing protein from Legionella pneumophila. The 
influence of SNPs on the functionality of prenylation motifs was investigated and found 
significant in the case of W353G in human ALDH3B2. Myristoylation of fly proteins 
important in asymmetric cell division and neuronal development (numb-A, neuralized B 
and C and Par-1 isoform Q) as well as homologous proteins from mouse (neuralized-like 1 
and 2) was demonstrated. The importance of distinguishing between isoforms with 
differing capabilities for posttranslational modifications is discussed. Myristoylation of the 
human transcription factor NFAT5-A was shown to influence localization to the nucleus 
suggesting a new mechanism for regulation of nuclear shuttling of transcription factors. 
Sequence similarities with the HATs from the GNAT superfamily suggested a function as 
histone acetyltransferase for mec-17 from C. elegans as well as homologous proteins from 
other organisms. Preliminary results of enzymatic activity tests and localization studies 
indicated that the protein has N-acetyltransferase activity; yet, histones might not be the 
primary substrate for acetylation by mec-17. A yeast two-hybrid screen revealed several 
proteins interacting with mouse mec-17 that could be either substrates or members of a 
multiprotein complex. Interaction with one of the found proteins, Kctd13, was verified 
biochemically by co-immunoprecipitation. 
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Zusammenfassung 
Sequenzanalytische Methoden ermöglichen die Vorhersage verschiedener Aspekte der 
Funktion von Proteinen, wie enzymatische Aktivität oder die Position von 
posttranslationalen Modifikationen in Proteinsequenzen. In den meisten Fällen bedürfen 
diese Vorhersagen experimenteller Überprüfung. Im Fall von posttranslationalen 
Lipidmodifikationen ist die gängige Methodik zeit- und arbeitsaufwendig. In dieser Arbeit 
wurde deshalb ein neuer in vitro Assay entwickelt, der auf der Detektion des Einbaus 
radioaktiv markierter Vorläufermoleküle der Lipidanker in in vitro translatierte Proteine 
mittels eines Dünnschichtchromatographie-Scanners basiert. Diese Methode reduziert den 
Zeitaufwand merklich, sie kombiniert die Bestimmung der Proteinausbeute und des 
eingebauten Lipidankers in einem einzelnen Experiment und ist für die Untersuchung von 
sowohl Prenylierung als auch Myristoylierung anwendbar. Diese Technik wurde zur 
Untersuchung von Prenylierung und Myristoylierung ausgewählter Proteine verwendet. 
Lokalisationsstudien mit GFP-Fusionsproteinen wurden zur Bestätigung der in vivo 
Relevanz der Ergebnisse herangezogen. Die prinzipielle Möglichkeit der Modifikation von 
Prenylierungsmotiven bakterieller Proteine durch eukaryotische Prenyltransferasen wurde 
in vitro am Beispiel eines bisher nicht charakterisierten Proteins aus Coxiella burnetii 
gezeigt, welches so genannte Ankyrin repeats enthält. Die Lokalisationsstudien legen auch 
die Prenylierung eines Proteins mit einer F-Box-Domäne aus Legionella pneumophila 
nahe. Weiters wurde der Einfluss von SNPs auf die Funktionalität von 
Prenylierungsmotiven untersucht und im Fall von W353G im humanen Protein ALDH3B2 
als signifikant bewertet. Die Myristoylierung von Fliegenproteinen mit biologischer 
Bedeutung in asymmetrischer Zellteilung und Entwicklung des Nervensystems (numb-A, 
neuralized B und C und Par-1 Isoform Q) sowie deren homologen Mausproteinen 
(neuralized-like 1 und 2) wurde gezeigt. Die Wichtigkeit der Unterscheidung zwischen 
Isoformen mit unterschiedlichem Potential für posttranslationale Modifikationen wird 
diskutiert. Die Myristoylierung des humanen Transkriptionsfaktors NFAT5-A sowie deren 
Bedeutung für dessen nukleare Lokalisation wurden gezeigt und legen einen neuen 
Mechanismus für die Regulierung des Kerntransports von Transkriptionsfaktoren nahe. 
Ähnlichkeiten der Sequenz von mec-17 aus C. elegans und homologen Proteinen aus 
anderen Organismen mit HATs aus der GNAT-Familie deuteten auf eine Funktion als 
Histon-Acetyltransferase hin. Die Ergebnisse von Experimenten zur Enzymaktivität und 
 viii 
Lokalisation des Proteins zeigen N-Acetyltransferase-Aktivität. Allerdings scheinen 
Histone nicht das bevorzugte Substrat zu sein. Mit einem Yeast 2-Hybrid Screen wurden 
daher einige Interaktionspartner des Maushomologs identifiziert. Diese kommen als 
Substrat oder Bestandteile eines Multiproteinkomplexes in Frage. Die Interaktion mit 
einem der Kandidaten, Kctd13, wurde durch Co-Immunopräzipitation biochemisch 
bestätigt. 
 ix 
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1 Aim of the thesis 
The ultimate goal in the so-called life sciences is to get to an understanding of the 
principles that make life possible at the molecular level. To achieve this, there are two 
classical approaches: one is the genetic approach with mutagenesis, looking for 
phenotypes and defining participation of gene products in certain pathways, resulting in 
what is often called “arrow”-science because there is no information about the kind of the 
interaction symbolized by the arrows. On the other hand, there is the biochemical approach 
with protein purification, in vitro tests, and structural analysis where few proteins are 
characterized in depth, but the capacity for large scale investigations is often limited. A 
combination of both ways can lead to a quite complete understanding of biochemical 
processes, but will take a lot of time. A third approach might help to speed up this process: 
the application of computational power on biochemical questions is able to support the 
classical research. With the availability of complete sequenced genomes, the scope of the 
applicability of sequence analysis tools has expanded. Genome wide in silico screens 
produce many, increasingly reliable predictions that, generally, require dedicated 
experimental efforts for their verification. Unfortunately, this is often not compatible with 
the way classical research labs work. This raises the need for request-based biochemistry 
specializing on experimental investigation of sequence analytical predictions. Based on 
predictions of the sequence analytical unit of our group, two projects were topic of my 
work. 
1.1 Development and application of an in vitro assay for the 
investigation of lipid posttranslational modifications 
Cell signaling is of crucial importance to every multicellular organism. This becomes even 
more evident from the observation that defects in signaling pathways are the major cause 
for cancer. Posttranslational modifications play an essential role in signaling. Lipid 
modifications act together with other factors to attach signaling proteins to membranes 
where they get in contact with their respective receptors. From there, signals have to be 
relayed to the appropriate targets in the cell, most often the nucleus where transcriptional 
adjustments take place in response to extracellular signals. This is often achieved by 
phosphorylation cascades, underscoring the importance of another posttranslational 
modification. 
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Focusing on lipid modifications, their importance in signaling makes proteins carrying 
lipid anchors as well as the enzymes attaching them to possible drug targets for the 
treatment of cancer and other diseases. Identification of a number of lipid modified 
proteins also permitted development of sequence analytical tools for identification of 
additional candidate proteins which could enlarge our knowledge about these proteins and 
the impact of their modifications and also broaden the range of applications for already 
available inhibitors targeting lipid modifications. Of course, these predictions need to be 
verified experimentally. A fast and reliable in vitro assay for the detection of prenylation 
has been developed previously in our lab. The goal in the first project was to apply this 
assay for the investigation of predicted prenylation candidates of special interest, e.g. 
proteins with prenylation motifs predicted to be influenced by single nucleotide 
polymorphisms and bacterial proteins. According to the current knowledge, bacteria do not 
possess prenyltransferases themselves. However, pathogenic bacteria could utilize the 
prenyltransferases of their eukaryotic hosts, a strategy that has already been observed for 
myristoylation. Furthermore, the scope of lipid modifications under investigation should 
be expanded by development of a similar tool for the detection of protein N-myristoylation 
and application for the investigation of selected candidate proteins predicted to carry this 
modification. Lipid–modified transcription factors are of special interest as membrane 
attachment via lipid modifications would imply a so far unknown mechanism for the 
regulated mobilization and nuclear shuttling of transcription factors. This issue was 
exemplarily studied with human NFAT5 isoform Aa. 
1.2 Characterization of a predicted protein 
N-acetyltransferase 
Based on sequence analysis, there is not only the possibility to predict the sites of 
posttranslational modifications, but based upon conservation of critical residues between 
similar proteins as well as comparison of critical features of protein structures or 3D 
models, prediction of the function of unknown proteins is possible under certain 
circumstances. In our group, a rather uncharacterized protein form Caenorhabditis elegans 
(C. e.) called mec-17b was predicted to act as a histone acetyltransferase (HAT). 
                                                
a
 Nuclear factor for activation of T cells 
b
 Mechanosensory abnormality 
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Homologous proteins were found in fly, mouse, and human. Preliminary results of 
enzymatic assays with recombinant protein and histone tail peptides were promising since 
they supported the working hypothesis of mec-17 homologues having protein N-
acetyltransferase activity, but the native substrates could not be identified. It is notable that 
the large family of proteins commonly termed histone acetyl transferases includes a lot of 
proteins also or exclusively targeting other proteins than histones. Therefore, it was 
decided to look for protein interaction partners of mouse mec-17 that might shed some 
light upon the functional impact of the protein and also reveal the true substrate. 
1.3 Summary of aims 
No case of a prenylated bacterial protein has been reported so far. Thus, the prenylation 
status of bacterial proteins with a predicted prenylation site from Coxiella burnetii 
(ankyrin repeat protein) and Legionella pneumophila (F-Box protein) will be investigated 
in vitro to check the general potential of bacterial proteins to be subject to prenylation by 
enzymes of eukaryotic host cells. Experiments with GFP fusion proteins will be performed 
to analyze the importance of prenylation for subcellular localization of the proteins in 
eukaryotic cells.  
Predictions indicate that the recognition of potential prenylation substrates by 
prenyltransferases might be affected by SNPs in the relevant region of the substrate 
sequence. The influence of SNPs on the in vitro prenylation of the human proteins 
ALDH3B2, BEX2, UTP14A, and FLJ20364 as well as the impact on localization of the 
different variants in human cells will be studied. 
Myristoylation plays an important role in the proper localization of proteins involved in 
asymmetric cell division and neuronal development. The prenylation assay will be adapted 
for the investigation of protein N-myristoylation and applied on the proteins numb A, Par-
1 Q, and Neuralized B and C from Drosophila melanogaster as well as neuralized-like 1 
and 2 from Mus musculus. In addition, the influence of myristoylation on localization of 
these proteins will be studied in transgenic flies and in murine cells, respectively. 
Prediction of myristoylation sites in the sequence of transcription factors suggests a new 
mechanism for mobilization and subsequent translocation of these proteins to the nucleus. 
To test this hypothesis, the in vitro myristoylation status and the influence on the 
localization of NFAT5-A will be analyzed exemplarily. 
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Mec-17 is predicted to be a histone acetyltransferase. Its N-acetyltransferase activity was 
demonstrated in vitro. A yeast 2-hybrid assay will be used to identify potential substrates 
as well as other members of a putative multiprotein complex. The interaction of these 
proteins with mec-17 will be further characterized with biochemical methods. 
This work features several topics that are mainly connected via the combined efforts of 
sequence analytics and biochemistry. For the sake of readability, the discussion of the 
results will follow their presentation for each topic separately. Thus, no extra section is 
present for the discussion. The main text is ended with a Conclusion section summarizing 
the findings, main conclusions, and the outlook. The work is completed with an Appendix 
that contains Materials and Methods for all experimental procedures, lists of Figures and 
Abbreviations as well as the Curriculum Vitae and the list of scientific publications of the 
applicant relevant for this work. 
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2 Introduction 
Posttranslational lipid modifications that were subject to investigation include protein 
prenylation and myristoylation. Additionally, a putative N-acetyltransferase is the topic of 
the second part of my work. An extensive review on protein prenylation co-authored by 
the applicant has been published recently. Therefore, this material is not repeated here, and 
the reader is referred to the journal1. An overview of protein N-myristoylation as well as 
acetyltransferases will be given to provide the background information on the research 
topics discussed in this work. 
2.1 Myristoylation 
Protein N-myristoylation is the covalent attachment of the 14 carbon saturated fatty acid 
myristate to N-terminal glycine residues2-5 via an amide bond6. Myristoylation of lysine ε-
amino groups has been observed, too, but is not topic of this work. Protein N-
myristoylation is specific for myristic acid over the more abundant palmitic acid7, usually 
occurs co-translationally8,9 after removal of the initiator methionine by cellular 
methionylaminopeptidases and is irreversible10, but exceptions exist: Posttranslational 
myristoylation has been shown for a protein from Dictyostelium discoideum11, and several 
proteins were shown to be myristoylated posttranslationally on internal glycine residues 
after caspase-mediated proteolytic cleavage leaving the glycine in an N-terminal 
position12-15. Contrary to the proposed irreversibility of myristoylation, an activity de-
myristoylating MARCKSa has been described16. The enzyme catalyzing protein N-
myristoylation is N-myristoyltransferase (NMT), a member of the Gcn5b-related N-
acetyltransferase (GNAT) superfamily of proteins. It catalyzes transfer of the myristoyl 
moiety of Myristoyl-Coenzyme A (CoA) to the free amino-group of the N-terminal 
glycine residue of the peptide substrate17. 
2.1.1 Function in membrane attachment 
The primary function of the lipid modification in most myristoylated proteins is promotion 
of membrane attachment. Myristoylation alone only provides a weak and reversible 
association with cellular membranes and, thus, is required but not sufficient for stable 
                                                
a
 Myristoylated alanine-rich C kinase substrate 
b
 General control of amino acid synthesis 
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membrane binding. This seems to be a wanted feature and important aspect of the function 
of myristoylation as NMT is highly selective for myristic acid, especially against the 
longer palmitic acid which would promote much stronger membrane association18. 
For a stable interaction with membranes, additional membrane attachment factors (MAFs) 
are needed which is in analogy to the two-signal model proposed for prenylation (C-
terminal modification by polyisoprenoids). Palmitoylation of one or more nearby cysteine 
residues increases the hydrophobic interaction with the membrane lipids19. Palmitoyl acyl 
transferases (PATs) are described as membrane bound20. Thus, the weak membrane 
binding provided by myristoylation is a prerequisite for subsequent palmitoylation. 
Positive charge clusters in vicinity of the myristoyl anchor often referred to as polybasic 
region (PBR) can enhance the interaction with the surface of membranes by electrostatic 
interaction with negatively charged phospholipid head groups21,22. Other examples of 
MAFs would be phospholipid binding domains, transmembrane regions, and direct 
protein-protein interactions with otherwise membrane-bound targets. 
2.1.1.1 Regulation of membrane binding 
Depending upon the additional factors strengthening membrane attachment, several 
mechanism exist for the regulation of reversible membrane association23. Palmitoylation, 
in contrast to myristoylation, is a reversible lipid modification easily removed by palmitoyl 
thioesterases. Thus, the localization to and the release from membranes is controlled via 
cycles of palmitoylation and de-palmitoylation. 
On the other hand, proteins harboring a myristoyl anchor in conjunction with a PBR can 
reversibly associate with membranes by a mechanism called “myristoyl switch”. Some 
proteins can change between two conformations with the myristate sequestered in a 
hydrophobic pocket of the protein in one state, but pointing outward ready for membrane 
insertion in the other conformation. There are different types of myristoyl switches 
classified upon the way the switch is triggered. Recoverin exposes its myristoyl anchor 
upon Ca2+-binding24, and Arfa releases its myristoyl moiety upon guanosine triphosphate 
(GTP) binding25. These proteins are examples of ligand switches. Another possible trigger 
                                                
a
 Adenosine diphosphate (ADP) rybosylation factor 
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is proteolytic cleavage as is the case for HIV-1a Gag. It is synthesized as a 55 kDa 
polyprotein precursor and associates with the plasma membrane mediated by 
myristoylation and a nearby positive charge cluster. After proteolytic cleavage, the 
myristate is buried in a pocket of the 17 kDa product26,27. A similar mechanism is found in 
the reovirus membrane-penetration protein Mu128. The third class is the so called 
electrostatic switch. For MARCKS, release from the membrane is triggered by 
phosphorylation of serine residues within the PBR disrupting the electrostatic interaction 
with the acidic phospholipid head groups29,30. Hisactophilin utilizes a pH-dependent switch 
with a histidine cluster that loses its positive charge above pH 731. 
2.1.1.2 Specific membrane targeting 
Combined use of different MAFs is not only necessary to provide stable membrane 
attachment but also to specify the exact targeting of lipid modified proteins to different 
membrane compartments. Localization studies with lipid modified GFPb-chimeras 
revealed that myristoylation excludes GFP from the nucleus and enables association with 
intracellular membranes, but plasma membrane localization requires a second signal32. A 
large fraction of myristoylated proteins is associated with the plasma membrane, but some 
are also localized to the endoplasmatic reticulum (ER), Golgi, mitochondrial membranes, 
or the nuclear envelope. There is even evidence for extracellular localization of a 
myristoylated protein33. To predict the final localization of a protein depending on the 
presence of different MAFs is not an easy task, especially when protein-protein 
interactions are involved. Furthermore, membranes are not a homogenous sea of lipids. 
The membranes of different compartments differ in lipid composition and, consequently, 
also in fluidity. There are even specific microdomains within membranes which are often 
referred to as lipid rafts. 
The targeting specificity of proteins harboring a myristoyl moiety in conjunction with a 
palmitoylation to the plasma membrane is explained by the so called kinetic bilayer 
trapping hypothesis34. The proteins are myristoylated co-translationally enabling them to 
reversibly associate with a variety of membranes. But only when they reach the plasma 
membrane, they get in contact with membrane-bound PATs adding the second fatty acyl 
                                                
a
 Human immunodeficiency virus 
b
 Green fluorescent protein 
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anchor stabilizing their interaction with the plasma membrane35,36. As membrane 
dissociation is much slower for doubly lipid modified proteins, they are kinetically trapped 
there. After they are stably bound at the plasma membrane, these proteins often become 
enriched in lipid rafts. These membrane microdomains are defined by resistance to 
extraction with nonionic detergents and a high content of sphingolipids and cholesterol. 
Since the lipids in raft-like membranes contain primarily saturated fatty acyl chains, they 
are present in the liquid ordered state (in contrast to the more fluid liquid crystalline 
phase)37. Therefore, it seems plausible that proteins modified by saturated fatty acyl chains 
preferably localize to lipid rafts while proteins with prenyl anchors are excluded due to 
their bulky branched structure38,39. It remains unclear whether myristoylated/palmitoylated 
proteins are preferably partitioned to preformed microdomains or their interaction with the 
membrane induces the formation of these rafts. Anyway, enrichment of N-terminally fatty 
acylated proteins in a sub-membranous microenvironment might provide increased local 
protein concentrations and thus facilitate protein-protein interactions40. 
A good example for the effect of different lipid anchors and localization to specific 
membrane microdomains are heterotrimeric G proteins41. Gα subunits are N-terminally 
acylated by myristate and/or palmitate while the βγ-dimer is prenylated at the C-terminus 
of the γ-subunit42,43. The βγ-dimer seems to dominate membrane binding characteristics of 
heterotrimeric G-proteins. In model membranes, they are found in non-lamellar phases rich 
in phosphatidylethanolamine44. The same microenvironment is preferred by G-protein 
coupled receptors (GPCRs). Actually, the prenyl anchor of the βγ-dimer as well as 
transmembrane helices of the GPCRs seem to actively influence the behavior of the lipid 
phase45,46. In contrast to the heterotrimer, the Gα subunit which is monomeric after 
nucleotide exchange induced by receptor activation prefers pure lamellar membrane 
structures excluding it from the microenvironment of the receptor and the βγ-dimer. 
Monomeric Gαi and Gαs were found to localize to lipid rafts while Gαq was concentrated 
in caveolae47. This translocation might facilitate interaction with effector proteins located 
in these membrane microdomains. 
Another interesting case of membrane targeting via fatty acyl modification was found in 
Leishmania major. Localization of HASPBa to the extracellular face of the plasma 
                                                
a
 Hydrophilic acylated surface protein B 
INTRODUCTION 
 9 
membrane was found to depend on N-terminal myristoylation and palmitoylation. This 
suggests a novel pathway for translocation of proteins to the surface of eukaryotic cells. 
This pathway seems to available also in higher eukaryotes33. 
2.1.2 More functions 
In addition to membrane targeting, several other functions for myristoylation have been 
reported in certain cases. Involvement of the myristoyl moiety in direct protein-protein 
interactions has been shown for the interaction of calmodulin with the protein kinase C 
substrates MARCKS and BASP1a as well as the HIV-1 protein Nef48-50. A role in protein 
stability and structural integrity has been described for the myristoyl moieties of 
calcineurin51. Finally, myristoylation is involved in regulation of enzymatic activity of Pto, 
a serine/threonine kinase from tomato52 and the c-Abl tyrosine kinase53,54. 
2.1.3 Function and clinical relevance of myristoylated proteins 
The first myristoylated proteins identified were cyclo-adenosine monophosphate (cAMP) -
dependent protein kinase3 and calcineurin B2. As more and more myristoylated proteins 
were discovered, it became clear that N-terminal modification with myristic acid is 
common for proteins from eukaryotes as well as their viruses. Some myristoylated proteins 
are also found in bacteria. Classification of known myristoylated proteins shows that there 
are only few large protein families with a conserved myristoylation motif. These are 
primarily involved in signaling and include the Gα subunits, Arfs, serine, threonine, and 
tyrosine kinases, and EF hand calcium binding proteins. Many smaller families exert 
specialized functions. 
Some members of the Gα family are myristoylated and palmitoylated42,43. Myristoylation 
is clearly required for membrane attachment but might also play a role in localization to 
specific membrane microdomains47, interaction with GPCRs55, and Gα structure56. 
Myristoylated tyrosine kinases also depend on the lipid modification for proper membrane 
localization and, in consequence, for their signaling function57. For c-Abl, an auto-
inhibitory mechanism utilizing a myristoyl/phosphotyrosine switch has been 
described53,54.Tyrosine kinases are of special clinical interest as mutations in this signaling 
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proteins are often associated with the development of cancer58,59. Since tyrosine kinases 
depend on myristoylation for signaling, increased NMT activity might be needed by 
cancerous cells. Indeed, elevated NMT activity was observed in early colonic 
carcinogenesis60 suggesting NMT as a target for chemotherapeutic drugs as well as a 
diagnostic marker61,62. The potential role of NMT in cancer has been reviewed recently63. 
A regulatory role of myristoylation has been described for the serine/threonine kinase Pto 
from tomato. It is involved in race specific resistance to Pseudomonas syringae. Kinase 
activity is repressed by intramolecular binding of the myristoyl moiety. Effector proteins 
of the intruder target the same region of Pto, thereby displacing the myristate and 
activating kinase activity resulting in induction of defense responses including 
hypersensitive cell death52. 
Calcineurin B was among the first proteins known to be N-terminally myristoylated2. 
Recently, the importance of myristoylation for membrane targeting has also been 
demonstrated for calcineurin B-like proteins from Arabidopsis thaliana64. Furthermore, a 
role of NMT and calcineurin in epilepsy was suggested65. 
Proteins that are myristoylated posttranslationally after caspase-mediated proteolytic 
cleavage build another interesting group. A previously internal myristoylation motif 
becomes N-terminal and, thus, accessible for NMT. Several such cases are known now. 
For the pro-apoptotic protein BIDa, myristoylation is involved in targeting to mitochondria 
followed by release of cytochrome c and programmed cell death12. A myristoylated 
fragment of cytoskeletal actin is also targeted to mitochondria after cleavage by caspase, 
but the functional role of this translocation remains unclear13. The myristoylated cleavage 
product of gelsolin is not targeted to mitochondria, but displays anti-apoptotic activity14, 
while myristoylation of the cleavage product of p21-activated protein kinase 2 potentiates 
late apoptotic events15. Taken together, this indicates an important role for 
posttranslational myristoylation in regulation of apoptosis. 
As mentioned above, NMT was suggested as therapeutic target in the treatment of cancer 
and epilepsy, but this is not the only application for drugs targeting NMT. NMT is 
essential for growth and survival of several human parasites including the fungi Candida 
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albicans66, Cryptococcus neoformans67, and the protozoa Leishmania major and 
Trypanosoma brucei68,69. Exploiting divergent peptide substrate specificity of NMTs from 
different species, some specific inhibitors targeting the NMTs of pathogenic organisms 
have been designed already70-75. Based upon a comprehensive analysis of different NMTs, 
the list of potential targets for selective NMT inhibition has been continued with 
Histoplasma capsulatum, Plasmodium falciparium, Aspergillus fumigatus, Trypanosoma 
cruzi, Giardia intestinalis, Entamoeba histolytica, Pneumocystis carinii, Strongyloides 
stercoralis, and schistosoma mansoni76. 
Myristoylation also has an important impact on various functions of many viral proteins as 
well as some from bacteria77. The large surface antigen of hepatitis B virus78,79, µ1 of 
reoviruses28, VP4 of picornaviruses80, and VP2 of polyomaviruses81 are myristoylated and 
the lipid anchor is required for viral entry into host cells. A mechanism with insertion of 
myristate into the host membrane has been proposed for some of them. Another function 
of viral proteins that can be dependent upon myristoylation is the assembly of viral 
particles. This has been shown for poliovirus82 and several mammalian retroviruses83-85, 
especially HIV27,86. There is also a conserved myristoylation motif in a superfamily of 
proteins from large deoxyribonucleic acid (DNA) viruses. One member of this group, the 
myristoylated transmembrane protein LR1 of Vaccinia poxvirus, is located in the first 
envelope and involved in acquisition of the second envelope87. Myristoylation is also 
found in non-homologous proteins of other large DNA viruses with similar membrane 
arrangements. Last but not least, myristoylated viral proteins are involved in manipulation 
of host cell signaling like the transforming protein of Rous sarcoma virus88 and the Nef 
protein of lentiviruses (including HIV) which requires myristoylation-mediated membrane 
binding for interactions with the endocytic machinery and signaling proteins to adjust host 
cells to optimal viral replication conditions89. As an example from bacteria, three type III 
effector proteins from Pseudomonas syringae need myristoylation for efficient membrane 
targeting and function90. NMT inhibitors have been suggested for antiviral therapy91, but, 
since viral and bacterial pathogens usually utilize the host NMT, it is much more 
complicated to achieve a specific effect on infected cells. 
2.1.4 N-myristoyltransferase 
The enzyme catalyzing the N-terminal myristoylation of proteins is called N-
myristoyltransferase (NMT). NMT is ubiquitous among eukaryotes, and in higher 
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eukaryotes there are two gene copies named NMT1 and 2. Homology between NMT1 and 
NMT2 is lower than between NMTs of one type in different species indicating two distinct 
families. Additionally, posttranslational modifications (PTMs) or alternative splicing seem 
to account for differing NMT isoforms varying in molecular weight and cellular 
localization92. 
The best characterized N-myristoyltransferase is Saccharomyces cerevisiae (S. c.) Nmt1p. 
It consists of 455 residues with an apparent molecular weight of ~ 55 kDa93. It was shown 
to be a cytosolic monomeric enzyme with a slightly alkaline pH-optimum (8.0) and no 
requirement for divalent cations. At least one histidine residue seems to be critical for 
activity which is consistent with the fact that at pH 6.0 and below the enzyme is inactive. 
Nmt1p has no intrinsic aminopeptidase activity94. Thus, it is dependent on the action of 
methionylaminopeptidases in advance. 
The structure of S. c. Nmt1p has been solved without and with substrates and/or substrate 
analogues. The Nmt fold consists of a saddle shaped mixed β-sheet surrounded by several 
α-helices. The protein has an internal pseudo-two fold symmetry with the N-terminal half 
responsible for myristoyl-CoA binding, while the C-terminal half predominately harbors 
the peptide binding site95. Based on kinetic studies, a Bi Bi reaction mechanism has been 
proposed with binding of myristoyl-CoA prior to peptide followed by release of CoA first 
and myristoylpeptide afterwards96. Consistent with this mechanism, the affinity of peptide 
substrates is much greater for the myristoyl-CoA-Nmt1p complex than for the apoenzyme 
suggesting either a direct contribution of myristoyl-CoA to the peptide binding site or a 
conformational change in the enzyme induced by myristoyl-CoA binding97. 
Resolution of the crystal structure of the enzyme as a binary complex with myristoyl-CoA 
revealed binding of the first substrate in a conformation resembling a question mark. Upon 
myristoyl-CoA binding, residues 34 – 55 are rearranged resulting in formation of the 310 
Helix A’. This helix, forming a positive dipole, and especially residues H38, K39, F40, 
and W41 contact the 3’ phosphate group of CoA. Amide nitrogens and side chains of the 
eC loop and the αC helix provide hydrogen bonds with the pyrophosphate group of CoA 
inducing also a first bend in the myristoyl-CoA conformation98. Interactions of the 
adenosine -3’-monophosphate-5’-diphosphate group have been suggested to provide 
mainly the binding energy for positioning of catalytically important regions of CoA 
substrates 99. This has been confirmed by binding studies of a substrate missing the 3’-
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phosphate and is also consistent with the fact that acyl-CoAs outside the catalytical 
specificity of Nmt can bind to the enzyme with high affinity and also generate a functional 
peptide binding site, but catalytic activity is markedly reduced due to improper positioning 
of the reactive group 100. Water mediated intramolecular hydrogen bonds between the O5p 
of pantetheine and the N6a amine of adenine induce a second bend directing the chain 
towards the active site. There, the reactive thioester carbonyl is hydrogen bonded to the 
backbone amides of F170 and L171, forming the so called oxyanion hole, providing the 
polarization of the carbonyl required for catalysis. Furthermore, the sulfur atom is located 
close to the N6a amine in hydrogen bonding distance. 
 
Figure 1: Secondary structure of ScNMT 
Position of secondary structure elements in the sequence of ScNMT according to the crystal structure101, with 
α-helices shown in blue and β-strands in green. 
This intramolecular interaction could stabilize the CoA thiol during the reaction. 
Additionally, release of CoA after the reaction is easier as a compact globular product. A 
third bend after C1m leads the acyl chain around the adenine where the side chains of 
W41, I168, I187, and Y204 block its way producing a fourth bend at C6m forcing the 
remaining stretch of C7 – C14 into a deep pocket within the protein core. Its depth is 
limited by side chains from V194, A202, and F425 and main chain atoms from T191, 
W200, and H201 providing an explanation how Nmt discriminates between substrates of 
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different chain length 98. In conclusion, three features act together to allow measurement of 
the acyl-CoA substrate length: The positioning of the reactive thioester carbonyl in the 
oxyanion hole, the block forcing the bend at C6m in the acyl chain, and the depth of the 
pocket. The requirement for a bent conformation of myristoyl-CoA is also confirmed by 
kinetic studies 102. 
A critical role was suggested for the Ab loop. Binding of myristoyl-CoA in the correct 
conformation alters its conformation through interactions via the loop B’A’ as well as 
direct interactions between myristoyl-CoA and the Ab loop. These interactions seem to 
stabilize the Ab loop in an open conformation and thus expose part of the peptide binding 
site 98,101. Beyond this function, the Ab loop is not likely to be directly in involved in 
peptide recognition and binding.  
The binding of the peptide substrate has been elucidated by the crystal structure of a 
ternary complex of Nmt1p with a myristoyl-CoA analogue and a peptide of the sequence 
GLYASKLA. The conformation of the bound model peptide reveals contact between the 
side chain of Leu2 and the myristoyl-CoA analog bending the peptide towards a binding 
groove. The path of the peptide is blocked at Ala4 by a large hydrophobic cluster forcing 
another bend that leaves the peptide main chain in a parallel β-sheet with strand βn of 
Nmt1p. This configuration is stabilized by several interactions with the enzyme as well as 
intramolecular hydrogen bonds, especially between Tyr3 carbonyl and Ser5 amide. The 
environment of the peptide also explains the amino acid restrictions observed: Leu2, Tyr3, 
and Ala4 experience a rather hydrophobic/aromatic environment with some potential 
hydrogen bonding partners for residues 2 and 3. Position 2 does not allow charged or 
bulky residues, while at position 3 and 4 there is enough space to accommodate all amino 
acids. Serine is strongly preferred at position 5. Ser5 is able to build hydrogen bonds with 
H221 and backbone amides of G418 and D417. Importance of H221 for peptide binding, 
but not for catalysis, has also been shown by mutation studies 103. Position 6 shows a 
preference for lysine, but all residues except for proline are allowed. The ε-amino group of 
Lys6 is coordinated by D417 as well as D22 and D23 101, and its aliphatic part is 
embedded in an hydrophobic/aromatic environment. The residues at position 7 and 8 have 
only few contacts giving the peptide binding groove an open-ended character and enabling 
it to accommodate nascent polypeptide chains for co-translational myristoylation 98. It is 
noteworthy that most residues involved in peptide binding are highly conserved in 
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mammalian NMTs, and substitutions might account for species specific substrate 
differences. 
With both substrates bound, the stage is set for the transfer of the myristoyl moiety to the 
peptide. Several prerequisites have to be fulfilled for a successful reaction: The thioester 
carbonyl of myristoyl-CoA needs to be polarized. This is achieved by interaction with the 
oxyanion hole. Hydrogen bonds with the main chain amides of F170 and L171 result in a 
partial positive charge of the carbonyl carbon facilitating a nucleophilic attack. The 
nucleophil is provided by proton transfer from the Gly1 amino group of the peptide 
substrate to the C-terminal carboxylate of Nmt which is consistent with the effect of C-
terminal deletions on catalytic activity 103. The hydroxyl group of T205 as well as the 
carbonyl group of N169 seem to stabilize the nucleophil and are conserved in all Nmts. 
Tyr3 of the peptide seems be involved, too. At this stage, the distance between the 
nucleophilic nitrogen of Gly1 and the electrophilic carbon is 6.3 Ǻ. For the nucleophilic 
attack, a rotation by 180° around Ψ is required which gives a good explanation for the 
absolute requirement for an N-terminal glycine for myristoylation. It is needed to provide 
rotational flexibility. Consistent with this model, mutation of glycine to alanine as well as 
proline and aromatic residues at position 2 result in poor substrates. After rotation, the 
interactions of Gly2 are replaced by even stronger ones with the carbonyl of N169 and the 
hydroxyl and carbonyl group of T205. Upon nucleophilic attack on the polarized thioester 
carbon, a tetrahedral intermediate is generated followed by release of free CoA. This 
anionic reaction product is stabilized by an intramolecular hydrogen bond between the 
sulfur atom and a nitrogen atom of the adenine moiety providing a compact leaving group. 
The final step is release of the myristoylpeptide 98. Product release also seems to be the 
rate-limiting step in protein N-myristoylation 104. 
Comparative studies demonstrated that the myristoyl-CoA binding site is highly conserved 
in NMTs from different species while there are some substitutions in the peptide binding 
pocket accounting for differences in substrate specificity105,106. Phylogenetic analysis 
yielded three clusters representing plant, fungal, and metazoan NMTs. Protozoa are in one 
group with fungi. This finding is consistent with the observations in substrate specificity. 
The altered tolerance for amino acids at position 3, 4, 7, and 8 of the substrate can be 
exploited for development of species-specific inhibitors72. 
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2.1.5 Sequence requirements for myristoylation 
Based upon analysis of the sequences of experimentally verified myristoylation substrates, 
NMT substrate specificity studies utilizing oligopeptides, and structural data or models of 
NMT from various organisms, the sequence requirements for protein N-myristoylation 
were refined76. It turned out that a simple model of amino acid restrictions at certain 
positions is not sufficient. Instead, a certain pattern of physical properties is required for 
recognition by NMT where compensatory effects among the sequence positions of the 
substrate make the context more important than single residues. Based upon the intensity 
of the interaction with NMT, the substrate sequence motif has been divided in three 
segments. 
The residues 1 to 6 have to fit into NMTs peptide binding pocket and are most restricted 
due to a multitude of specific interactions. Most NMT residues involved in recognition of 
substrate positions 1 to 6 are highly conserved. At position 1, glycine is absolutely 
required. This is due to the rotational flexibility required by the reaction mechanism of 
NMT as discussed previously. As position 2 and 5 show a tendency towards small amino 
acids compared to the average peptide, side chain volume seems to be an important factor 
there. Volume compensation is possible to some extent between 2 and 3. Polarity is 
preferred at 2 and 3, but fungal NMTs are more tolerant towards hydrophobic residues 
than NMTs from higher eukaryotes. At position 4, large and hydrophobic amino acids are 
preferred with the exception of certain fungal NMTs that have a smaller binding site there. 
Like position 2, residue 5 should be small and polar, but serine and threonine are preferred 
as they are additionally stabilized by hydrogen bonding. Furthermore, backbone flexibility 
is required between position 3 and 5. At position 6, lysine and threonine are preferred since 
the polar head group is stabilized by hydrogen bonds and the aliphatic region of the side 
chain by hydrophobic interactions. 
The second segment consists of residues 7 to 11. These show weak interactions with the 
surface of the enzyme at the mouth of the catalytic cleft. The lack of tight specific 
interactions comes along with no clear amino acid preferences but a more general 
requirement for certain physical properties. At position 7, turn-like residues are preferred 
while bulky hydrophobic residues are disfavored, but volume compensation is possible 
between residues 7 and 9. Position 8 shows an increased occurrence of basic amino acids, 
but there is no obvious reason for this from the interaction with the enzyme. This 
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phenomenon rather seems to reflect the fact that myristoylation often acts in concert with a 
PBR. For both position 7 and 8, negative charges are not well accommodated by the 
enzyme, but NMTs of fungi and protozoa are more restrictive against them than NMTs of 
higher eukaryotes. Position 9 is preferably occupied by polar amino acids with flexible 
backbone. There is a general trend towards small and polar residues until position 11, 
especially between 8 and 10 only limited hydrophobicity is allowed. 
Positions 12 to 17 fulfill the function of a spacer connecting the bulk of the substrate 
protein (which is likely to adopt a globular conformation) to the modified stretch. Since 
this segment of the motif is exposed to the aqueous cytosolic environment (or to 
hydrophilic membrane lipid head groups later on), a certain content of polar residues is 
required. Again, a limited amount of hydrophobic residues can be compensated for. For 
entering of the N-terminus of the substrate into the catalytic pocket of NMT, the whole 
stretch from 7 to 17 requires conformational flexibility to adopt an extended conformation. 
It has to be easily unfolded or permanently without secondary structure. Such a linker 
segment seems to be a general requirement for posttranslational modifications. In case of 
internal modifications, two linker regions are needed flanking the site of the modification. 
The length of the linker is determined by the roughness of the surface of substrate and 
enzyme107. 
2.1.6 The MYR-Predictor 
Based upon the refinement of the sequence motif for protein N-myristoylation, a predictor 
has been developed and is available online at 
http://mendel.imp.ac.at/myristate/index.html108. Both amino acid preferences and required 
physical property pattern were implemented into a scoring function. Thus either many 
small deviations of the requirements or one drastic can be responsible for classification of 
query sequences as no myristoylation target. The contributions of different terms are 
summed up in the scoring function facilitating identification of the critical terms. Separate 
prediction functions were implemented for fungal as well as for eukaryotic and viral 
sequences to take the differences in substrate specificity between NMTs from different 
species into account. It is also possible to look for putative internal myristoylation sites. In 
this case, the potential protease cleavage site preceding the glycine is compared to 
documented cases of internal myristoylation after proteolytic cleavage. 
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Application of the predictor to protein databases yielded lots of interesting putative 
myristoylation targets109. 34 new potential myristoylation targets in fungi were added to 
the 22 fungal proteins present in the learning set, and 266 new putative targets were 
identified in higher eukaryotes and viruses. Many predictions add new members to protein 
families with known myristoylation targets like 16 α-subunits of G proteins, 7 tyrosine –
protein kinases, and 12 serine/threonine-protein kinases. Of special importance seems to be 
the combination of calcium import and myristoylation as indicated by 34 known and 32 
predicted myristoylation targets with annotated calcium binding sites. Some of the new 
candidates might also utilize a calcium-myristoyl-switch mechanism. These large families 
are examples of a myristoylation motif conserved over several species. This strengthens 
the predictions and suggests importance of the myristoylation for the biological function of 
the protein families. The evolutionary conservation of predicted myristoylation motifs has 
been evaluated in groups of homologous proteins. The results are available as MYRBASE 
at http://mendel.imp.ac.at/myristate/myrbase/ 110. Several large protein families probably 
representing the oldest cases of myristoylation are found in opposition to a lot of families 
with only few members that might carry out specialized functions. 
The candidates with no similarity to the known cases are especially interesting as they 
expand the functional spectrum of myristoylated proteins. A new group of proteins 
predicted to be subject to myristoylation are plant specific disease resistance proteins. 
Parasitic bacteria inject avirulence proteins that are often myristoylated into host cells via 
the type III secretion system. Myristoylation of the disease resistance genes could be 
necessary for the interaction with the avirulence proteins required for induction of the 
adequate immune response. Recently, the regulation of a disease resistance protein from 
tomato by myristoylation has been shown52. A role for myristoylation in ubiquitination is 
suggested by prediction of a myristoylation motif for several ubiquitin-specific proteases 
as well as proteins containing putative RING zinc finger domains commonly found in 
ubiquitin ligases. One example of this group is the Notch pathway protein neuralized, a 
peripheral membrane protein involved in establishing signaling asymmetry111. The 
myristoylation status of the mouse and fly homologues of neuralized was investigated in 
this work, and the myristoylation motif is also conserved in human, frog, and worm. A 
myristoylation motif is also conserved for TOM40a involved in protein import into 
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mitochondria which is quite surprising for an all-β integral membrane protein. The role of 
myristoylation in the function of voltage gated potassium channels also remains unclear. A 
channel as well as a group of modulatory proteins interacting with these channels is 
predicted to be myristoylated, and proteins of this group that are not subject to 
myristoylation are palmitoylated instead indicating the importance of lipid modification112. 
While GTPases are usually prenylated, an interferon-γ induced GTPase involved in 
mammalian immune response is predicted as a substrate for myristoylation.  
This finding adds another example to the assumption that the myristoylation motif is used 
as an exchangeable module in evolution together with other MAFs. There are already 
several known cases supporting this idea. Gα-subunits carry myristoyl and/or palmitoyl 
anchors in different number42. In Arabidopsis thaliana, a protein of the Rab/Ypt GTPase 
family was found that lacks the typical C-terminal prenylation motif, but harbors N-
terminal sites for myristoylation and palmitoylation instead113. Functional replacement of 
the N-terminal double acylation with myristate and palmitate by a transmembrane domain 
was demonstrated for endothelial nitric-oxide synthase114. A phosphoinositide-specific 
phospholipase C from Trypanosoma cruzi is N-terminally myristoylated and palmitoylated 
replacing the pleckstrin homology domain usually mediating membrane interactions of 
these proteins115. Of course, these exchanges of MAFs often come along with differences 
in function and/or localization. Furthermore, while it is well established that palmitoylation 
or PBRs act synergetic with myristoylation in membrane attachment, other MAFs like 
lipid-binding domains, transmembrane regions, and protein-protein interaction domains 
are clearly overrepresented in the predicted substrates. The functional importance of these 
combinations needs further investigation. 
To sum up, a multitude of new myristoylation targets are predicted and await experimental 
verification. Of course, some of them might deserve elaborate investigation of their 
function and the impact myristoylation has on it, but to make a pre-selection it would be 
convenient to have a fast and reliable method for testing protein N-myristoylation at hand. 
Furthermore, the simple experimental verification of the ability of proteins to be a 
substrate for myristoylation gives the opportunity to enlarge the learning set available for 
the prediction function which both helps in improvement of the quality of the predictions 
as well as development of more species-specific prediction functions in addition to the 
ones available for fungi and higher eukaryotes. Thus, a new in vitro assay for investigation 
of protein N-myristoylation was developed and applied on selected candidate proteins. 
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2.2 Mec-17 – histone acetyltransferase or not? 
2.2.1 Chromatin structure 
DNA is nature’s medium for storage of information. The building plan for the proteins that 
carry out most biological processes required for life is encoded in DNA by linear 
combination of four bases. This information is present in every single cell. As one can 
imagine, storing all this information in a linear code of just four elements yields quite a 
long string. Somehow this string, which is about 1 -2 meters long in eukaryotic cells, has 
to fit into the nucleus of the cells and be available at the same time for fundamental 
cellular processes. Transcription is required for protein synthesis, replication for 
proliferation, and DNA repair to maintain the integrity of the genome. In a review, the 
problem is depicted very nicely: “Imagine trying to stuff about 10.000 miles of spaghetti 
inside a basketball. Then, if that was not difficult enough, attempt to find a unique one-
inch segment of pasta from the middle of the mess, or try to duplicate, untangle and 
separate individual strings to opposite ends”116. Thus, it is obvious that a sophisticated 
mechanism is required to store DNA in a convenient way. In a way, the comparison of 
DNA with spaghetti also fits for the method that is used for compaction of DNA to fit into 
the nucleus. Most people tend to wrap the spaghetti around a fork, and this is what is 
basically done in the first step with DNA, too. In the so called nucleosome core, the 
smallest unit for organization of DNA, 147 base pairs (bp) in a left-handed superhelix are 
wrapped 1.65 times around a histone octamer. These nucleosome cores are repeated with 
10 – 60 bp of linker DNA in between resulting in a fiber with a diameter of ~10 nm that 
presents the characteristic look of “beads on a string”117,118. The linker histone H1 seems to 
neutralize the negative charges of the linker DNA backbone reducing the electrostatic 
repulsion between the DNA strands and changing the exit path of the DNA from the 
nucleosome core to allow a more compact folding. Together, the core histones with the 
DNA wrapped around it as well as the linker DNA and the linker histone build a 
nucleosome. Interactions between the nucleosomes lead to the assembly of higher order 
structures that are stabilized by the linker histones resulting in formation of a compact 30 
nm fiber. Fiber-fiber interactions increase the compaction of DNA to ~100 nm thick 
chromonema fibers. The maximum level of condensation is achieved during mitosis when 
the chromosomes are separated into the daughter cells. Metaphase chromosomes are 
~1400 nm thick. It is tempting to view packing of DNA into chromatin similar like protein 
INTRODUCTION 
 21 
structure: the primary structure is the linear arrangement of nucleosomes, the secondary 
structure would be the 30 nm chromatin fiber, and chromonema-like fibers represent the 
tertiary structure119. 
2.2.1.1 Histones 
The nucleosome core is the basic unit of chromatin structure with DNA wrapped around a 
histone octamer. This multimeric protein is built of two copies of each of the core histones 
H2A, H2B, H3, and H4. Four so called “histone-fold” dimers assemble stepwise into the 
complete octamer. Two H3-H4 dimers associate to build a tetramer which then interacts 
with two H2A-H2B dimers. All four core histones consist of two functional domains, the 
“histone-fold” motif which accounts for histone-histone interactions required for 
octamerization as well as histone-DNA contacts, and the so-called histone tails which are 
the site of various posttranslational modifications and involved in interactions with linker 
DNA and between nucleosomes120. 
The histone-fold domains of the different core histones share a common structural motif 
that consists of three α-helices connected by two loops. These are the basis for assembly of 
the crescent-shaped heterodimers via a “handshake motif”. The interactions between the 
heterodimers are mediated by 4 helix bundles. One such interaction between the H3 
histones of the H3-H4 dimers leads to assembly of the tetramer. Subsequently, the full 
octamer is put together by 4 helix bundles between the H4 and H2B histones. The two 
H2A-H2B dimers are not connected this way leaving the respective helices in H2A 
unused. These would be available for internucleosome interactions, although current 
models for higher order structure would not fit to such an interaction. 
Each heterodimer is able to bind about 2.5 turns of DNA double helix bent around the 
curvature of the structure. Summing up over the octamer, the histone fold domains are able 
to harbor 121 bp of DNA with 27 – 28 bp bound to each dimer and 4 bp in between as a 
linker121. Although binding of DNA to histones occurs primarily via the negatively 
charged phosphodiester backbone, the positioning of the nucleosomes is at least partially 
dependent on the DNA sequence. The wrapping of DNA around the histones requires a 
certain degree of flexibility or bendability. Additionally, some direct contacts between the 
histones and base pairs could also account for sequence selectivity. 
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The second functional domain of the core histones are the histone tails. These are segments 
at the N-terminus of the core histones with a length of 20 to 35 residues rich in basic 
amino acids. H2A has an additional 37 residue C-terminal tail. The histone tails do not 
significantly contribute to nucleosome structure and stability, they seem to emanate 
radially from the nucleosomes. They were shown to contribute to sequence dependent 
nucleosome positioning122, but their main function seems to lie in higher order compaction 
of chromatin which is underscored by the result that removal of the tails blocks 
condensation at the level of the 10 nm fiber123,124. The condensation mediated by the 
histone tails is stabilized by linker histones that are not structurally related to the core 
histones, which seems to be required for further compaction125,126. 
2.2.2 Regulation of chromatin structure 
Assembly of DNA and histones into nucleosomes and higher-order structures provides the 
compaction necessary to store the whole genome in the nucleus of a single cell. However, 
the challenge is not over at this point, it has just begun. Certain pieces of DNA must be 
accessible at specific time points for replication, transcription, and repair. These processes 
require the stepwise assembly of large protein complexes which can be viewed as 
molecular machines. But it is hard to imagine how the protein machinery required for these 
processes could target specific sequence stretches and attach to them to carry out their 
tasks in the fully condensed state. In fact, cells use the compaction of DNA regions into 
heterochromatin to keep them transcriptionally silenced. Thus, chromatin can not be a 
rigid structure, but has to be a highly dynamic construct undergoing regulated unfolding 
and folding. 
For fully condensed metaphase chromosomes, fiber diameters up to 300 nm were 
shown127. At mitotic exit to interphase, regional decondensation down to chromonema 
fibers with 60 to 80 nm diameter was observed128. In a model system, activation of 
transcription resulted in decondensation to 80-100 nm fibers which were suggested as 
basic higher order structure allowing gene expression129. A second model in a more natural 
context lead to observation of at least fully condensed 30 nm fibers in regions of active 
transcription130. Thus, it seems not necessary to fully untangle DNA from the histones to 
provide the accessibility required. However, regulated chromatin remodeling is certainly 
needed. Several mechanisms act together to achieve this goal. 
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First of all, chromatin is not only built of the canonical nucleosomes. There are several 
histone variants with special functions in chromatin structure. One of them has been shown 
to be essential for centrosome assembly and function, and an H3 variant replaces canonical 
H3 during transcription. Several variants of H2A have been found, one of them involved in 
X-chromosome inactivation. H2AZ, another variant of H2A, has a different tail 
sequence131 and is involved in transcriptional activation and repression132,133. It seems to 
exert a role in chromatin folding as it prevents further condensation of 30 nm fibers134. 
However, not much is known at present about the targeting of these histone variants to 
specific regions of chromatin. In addition, also non histone proteins were shown to bind to 
nucleosomes. These so-called high mobility group proteins (HMG) also seem to affect 
chromatin structure135. 
In addition to incorporation of variants of histones into chromatin for special functions, 
two major mechanisms act together in chromatin remodeling. Proteins of the Swi2 
superfamily use the energy of adenosine triphosphate (ATP) hydrolysis to modify the 
chromatin structure. The second mechanism is based on posttranslational modification of 
the histone tails. Both activities are present in protein complexes often recruited by 
transcriptional activators136. It is not clear whether there is some sort of order for the action 
of these mechanisms. ATP-dependent remodeling has been shown to be prerequisite for 
posttranslational histone modifications in the case of genes transcribed during mitosis 
when the genome is highly condensed. On the other hand, the reverse order is observed for 
cell-cycle independent genes137. 
2.2.3 Histone tail modifications 
Histones are subject to a multitude of posttranslational modifications, most of them 
occurring at the histone tails. In fact, it seems like almost every solvent accessible residue 
of histones is modified in one way or another. From the already highly conserved histones, 
the tail regions are evolutionary conserved most indicating the importance of the presence 
of the residues that are target of covalent modifications. Posttranslational modifications of 
histones include acetylation, methylation, phosphorylation, ubiquitination, sumoylation, 
glycosylation, and ADP-ribosylation with the first three of the modifications occurring 
most frequent. Acetylation and methylation can occur at the side-chain amino groups of 
lysine and arginine. For methylation, complexity is increased by the fact that arginine 
residues can carry two methyl groups and lysine up to three. Phosphorylation takes place 
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on serines and threonines, and the small protein ubiquitin as well as the related SUMOa are 
attached to lysine side chains. A wide variety of functions has been addressed to these 
modifications. Acetylation is generally associated with transcriptional activation, although 
there are exceptions138. The various methylation marks were shown to be involved in both 
activation and repression of transcription depending on the site and number of methyl 
modifications137. For histone phosphorylation, a role in transcriptional activation and 
chromosome condensation in mitosis was shown139. Reversible ubiquitination of core 
histones H2A and H2B is associated with transcriptional activity. 
2.2.3.1 The histone code 
Given the multitude of modifications, the existence of a histone “code” was proposed. This 
word is rather misleading as it implies that a certain modification does always have the 
same function. But the functional impact of histone modifications seems to be the result of 
the interpretation of a whole pattern of modifications depending on the gene and the 
cellular context140. Some marks are needed for further modification while others may 
block modification of nearby residues. Two roles have been postulated for the histone 
code. The first is to provide heritable chromosome-specific epigenetic marks. Somehow a 
cell passes on the pattern of active and silenced genes to its daughter cells. Some sort of 
marks has to survive DNA replication and segregation of chromosomes during mitosis. 
Histone modifications have been suggested to be involved in this process, especially 
methylation as it is viewed as a rather stable modification in contrast to others, although 
enzymes responsible for removal of methyl marks have been discovered recently116,141,142. 
However, to which degree histone modifications are responsible for epigenetic memory is 
still controversial and needs further investigation143. On the other hand, the combinatorial 
function of posttranslational histone modifications in localized control of events on 
chromatin including transcriptional activation and repression as well as histone deposition 
in S-phase or chromosome condensation in mitosis is out of question. 
2.2.3.2 Targeting of histone modifications 
A multitude of cellular processes are influenced by one or the combination of several 
histone modifications. Thus, their placement needs to be precisely targeted. This is 
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achieved in part by the inherent substrate specificity of the enzymes responsible for the 
modifications but also by their recruitment to specific loci via association with gene-
specific activators or repressors or with the RNA polymerase II holoenzyme complex. 
Enzymes involved in DNA repair were shown to be recruited directly by DNA lesions. A 
special case is the methylation of histone 3 lysine 9 which seems to be targeted by small 
non-coding ribonucleic acids (RNAs) via the RNA interference (RNAi) pathway resulting 
in formation of heterochromatin required for centromere function116. Apart from the 
precisely targeted modifications required for specific functions, there are bulk chromatin 
modifications, too, involved in histone deposition after passage of a replication fork or 
chromosome condensation in mitosis. For example, the non-targeted action of histone 
acetyltransferases and deacetylases seems to maintain some sort of equilibrium level of 
histone acetylation in yeast144. After targeting of the histone modifying enzymes to certain 
loci, the exact point of modification is determined by their substrate specificity but also by 
cross-talk with other marks that are already present. These can promote or inhibit further 
modifications, some types of PTMs might rival for the same residue. Thus, a pattern 
coding for a specific function can be built up sequentially. 
2.2.3.3 Function of histone modifications 
When the modifications are finally in place, they somehow have to exert their function. 
Two models have been proposed. The first is based upon the change of the charge of 
histone tails by PTMs. Elimination of positive charges from the overall basic histones 
could weaken the interaction with the negatively charged DNA backbone. However, a lot 
of modifications would be necessary to significantly reduce the overall charge of histones 
given the number of basic residues present. Furthermore, hyperacetylation did not release 
histone tails from DNA in vitro. It seems more plausible that removal of critical charges 
destabilizes internucleosome contacts disrupting the higher-order structure of chromatin 
and, thus, reducing DNA compaction145. 
In the second model, PTMs modify the surface for protein interactions creating new 
binding sites for proteins which then in turn exert the functions mediated by the PTMs. 
Evidence for this model comes from the discovery of specific binding domains. 
Bromodomains were shown to bind to acetylated lysines. Some of them are even specific 
for a certain acetylated lysine residue. However, it is not clear whether all bromodomains 
bind acetyllysine. Bromodomains are present in many transcription and chromatin 
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regulators like histone acetyltransferases (HATs) or ATP-dependent chromatin 
remodelers146,147. The chromodomain was discovered as methyl-lysine binding domain, but 
later on chromodomains were shown to interact with diverse targets including histones, 
DNA, and RNA. Chromodomains are present in many regulators of chromatin 
structure148,149. Tudor-, MBT-, and PHD-domains recognize methyllysines, too150. The 
model of histone modifications as protein binding sites also gives a nice explanation for 
cross-talk as neighboring PTMs could easily influence the binding of these specific 
domains. Several modifications could act together to give a certain function in different 
ways. Either a specific pattern of modifications is recognized by a single binding protein 
which would require that they are on the same histone tail or at least the same nucleosome. 
On the other hand, each modification could be recognized separately by individual proteins 
which then interact physically or functionally. This would allow the modifications to be 
quite distant from each other. In each case, the binding proteins could be the basis for the 
assembly of multiprotein complexes that exert the specific functions. However, the basic 
coding unit could either be a single nucleosome or a chromatin stretch of undefined size143. 
Taken together, both proposed models how posttranslational modifications of histone tails 
influence chromatin structure provide some explanations. Furthermore, they are not 
exclusive, so it is very likely that reality is more closely to a combination of both models. 
2.2.4 Histone acetylation 
The first hint on a role for histone acetylation in transcriptional control came from the 
observation that actively transcribed regions tend to be hyperacetylated whereas 
transcriptionally silent regions tend to be hypoacetylated151. All core histones except H2A 
have four or five potential acetylation sites giving a total of 26 sites for acetylation on a 
nucleosome. Acetylation of histone tails was shown to disrupt higher order chromatin 
folding152 resulting in better accessibility for proteins interacting with DNA. Furthermore, 
acetylation maintains the unfolded structure of transcribed nucleosomes153, and acetylation 
of 46% of all acetylation sites is sufficient to facilitate transcription. Despite the obvious 
link between histone acetylation and transcription, it is important to distinguish different 
types of acetylation. Partial chromatin decondensation induced by broad histone 
acetylation does not directly correlate with active transcription, but rather marks regions of 
transcriptional competence. In this state, promoters are accessible for the transcription 
machinery and transcription elongation is supported, too. In contrast to broad acetylation, 
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activation of transcription often comes along with targeted histone acetylation at promoters 
and could function in recruitment of other chromatin remodeling activities154. 
The two models described previously also fit for the description of the function of histone 
acetylation. Neutralization of positive charges by acetylation could weaken the interaction 
with the DNA backbone as well as interactions required for higher order chromatin 
structure. Additionally, acetylated residues could act as docking sites for proteins that, in 
turn, carry out the functions mediated by histone acetylation. The best characterized 
module for this purpose is the bromodomain which is able to recognize acetyllysine155. 
This domain is present in many regulators of transcription and chromatin structure156. 
Bromodomains were shown to play a role in five functions so far. First, they are important 
for chromatin acetylation by HATs. Bromodomains present in several HATs are required 
to anchor them to acetylated chromatin. Second, ATP-dependent chromatin remodeling 
complexes like SWI/SNF and RSC require their bromodomains for acetylation dependent 
chromatin remodeling. The third function is in organization of chromosome and chromatin 
domains. Brd proteins build a physical barrier between euchromatin and heterochromatin, 
associate with acetylated chromatin regions in interphase and/or mitosis, and reorganize 
chromatin. Fourth, bromodomains also recognize acetylated non-histone proteins. Several 
transcription factors and chromatin remodelers are subject to lysine acetylation. In some 
cases, it has been shown to promote association of these proteins with HATs. Finally, 
bromodomains can act as regular protein- or DNA-binding modules157. 
2.2.5 Histone acetyltransferases 
Although the connection between reversible histone acetylation and transcriptional control 
has been known for quite some time, it took until the 90s to identify the enzymes 
responsible. The breakthrough was the discovery of a protein from Tetrahymena 
thermophila that has histone acetylation activity and is related to the yeast protein Gcn5158. 
Gcn5 was known before as a transcriptional coactivator, and the demonstration of its HAT 
activity established the connection between histone acetylation and transcriptional 
regulation. Since then, several transcriptional co-activators and co-repressors were shown 
to possess histone acetylation and deacetylation activity, respectively159. 
INTRODUCTION 
 28 
2.2.5.1 HAT families 
Histone acetyltransferases are grouped in several families which display high sequence 
similarity between families but poor to no similarity between families159. These are named 
Gcn5/PCAFa, p300/CBPb, MYSTc, SRCd, TAFII250e, Hat1, and ATF-2f. The members of 
these families combine HAT domains of different size with other protein domains like the 
bromodomain in the case of Gcn5/PCAF, CBP/p300, and TAFII250, the chromodomain 
and a cysteine-rich zinc-binding domain in MYST as well as cysteine-histidine rich 
domains in CBP/p300. ATF-2 differs from the others because it is the only sequence 
specific DNA-binding transcriptional activator with HAT activity. The diversity of HAT 
families enables them to exert various functions including a role in transcriptional 
activation and silencing, formation of leukemic translocation products, and dosage 
compensation in Drosophila melanogaster. A subgroup of cytoplasmic enzymes also 
called B-type HATs acetylate newly synthesized histones prior to their incorporation into 
chromatin. The best studied example is Hat1160. The HATs with nuclear localization 
involved in transcriptional control are also called A-type HATs. 
2.2.5.2 HAT structure and mechanism 
Some HATs were shown to belong to the Gcn5 related N-acetyltransferase (GNAT) 
superfamily, a family of proteins with diverse functions. In addition to HATs, the GNAT 
superfamily also includes aminoglycoside N-acetyltransferases, serotonin N-
acetyltransferase, glucosamine-6-phosphate N-acetyltransferase, mycothiol synthase, 
protein N-myristoyltransferase, and the Fcm family of acyltransferases. Members of this 
family display limited sequence homology in four segments called motif A, B, C, and D. 
Although the pairwise sequence identity between the different members of the GNAT 
family ranges only between 3 and 23%, they all share a structurally conserved fold 
consisting of an N-terminal β-strand, two α helices, three antiparallel β strands, a 
“signature” central helix, a fifth β strand , a fourth α helix, and a final β strand161. 
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Figure 2: Conserved fold of Gcn5 family members 
(A) Topology of the core GNAT fold. From N- to C-terminus, structural elements are colored green, yellow, 
red, and blue. The N-terminal strand β0 is not completely conserved and the deep blue C-terminal strand may 
be contributed by the same or another monomer. (B) Superposition of 15 GNAT structures. Residues with 
root medium square deviation < 2,7 Ǻ are shown in red161. 
The histone acetyltransferases of this family, including Gcn5, PCAF and CBP/p300, show 
no significant homology in motif C, but motifs A, B and D form a structurally conserved 
domain involved in binding of CoA. Other HATs which do not belong to the GNAT 
superfamily were suggested to contain a structurally similar motif for CoA interaction. The 
A-D motif consists of three antiparallel β-strands followed by a helix underneath the sheet 
in parallel orientation. The similarities in HAT structures extend this motif with a 
conserved loop – β-strand C-terminal of the helix. Together, this structural element is 
approximately at the center of the HAT proteins and viewed as core domain. It is believed 
to play a role in Acetyl-CoA binding and catalysis. Coenzyme A is bound in a bent 
conformation. Motif A makes most of the contacts, especially with the pantetheine chain 
and the pyrophosphate group of CoA. A catalytical role has been suggested for a 
conserved glutamate residue (E173 in yGCN5) and confirmed by mutagenesis162. It seems 
to act as general base to facilitate deprotonation of the substrate lysine and is surrounded 
by non-polar residues raising the pKa value. Structural superposition of HATs from 
different families reveals corresponding conserved glutamate residues in similar 
arrangement in MYST and Hat1 families160. 
In contrast to the core domain, the domains at the N- and C-terminus seem to mediate 
histone substrate binding. The sequence divergence found in these regions might account 
for different substrate specificities of the HATs. Nonetheless, superposition of the core 
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domains reveals an N-terminal helix-loop and a loop-helix motif in the C-terminal domain 
found in other HATs, too. Furthermore, these regions play a critical role in substrate 
binding and contain residues highly conserved in the respective families. The substrate is 
bound in a long channel in a random coil conformation. Most interactions with the enzyme 
occur via main chain atoms of the substrate and thus do not contribute to substrate 
specificity. Selectivity is provided by extensive interactions of few critical residues as well 
as by the requirement of the substrate to adopt the needed conformation. Other histone 
modifications were shown to play a role in selectivity, and to some degree the substrate 
specificity is also determined by other proteins present in multisubunit complexes 
harboring the HATs as catalytic subunits. 
Despite the structural similarities between different HATs, their mechanisms differ. The 
kinetic mechanism of Gcn5 and P/CAF is ordered Bi-Bi. Acetyl-CoA binds first followed 
by the histone substrate. CoA binding was shown to induce localized conformational 
changes in the enzyme, especially the histone substrate binding groove is widened160. The 
carbonyl of Acetyl-CoA is hydrogen bonded to the enzyme polarizing it for nucleophilic 
attack by the amino group of the substrate and stabilizing the anionic tetrahedral 
intermediate161. After transfer of the acetyl moiety to the substrate, the acetylated histone is 
released prior to CoA163,164. In contrast, MYST HATs utilize a ping-pong mechanism 
where the acetyl group is transferred to a cysteine residue at the active site. After 
dissociation of CoA, the acetyl group is moved onto the histone substrate165. 
2.2.5.3 HAT complexes 
Some conserved patches in HATs are not involved in substrate binding. These regions are 
likely to act as protein interaction sites. In fact, most HATs are in multisubunit complexes 
in vivo157. The complexes characterized best are the yeast SAGAa/human PCAF/Gcn5 and 
yeast NuA4b/human Tip60c complexes. Both have roles in regulation of transcription166,167. 
HAT proteins and their complexes have similar but distinct substrate specificity. 
Furthermore, the complexes are typically more active than the catalytic subunits alone. 
Thus, associated subunits are involved in regulation of the HAT activity as well as in 
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recruiting substrates. For example, yeast Gcn5 alone can only acetylate free histones, but 
Gcn5 functions as a catalytic subunit in two native HAT complexes named ADA and 
SAGA, which acetylate nucleosomal histones166. Furthermore, Gcn5 alone acetylates 
predominately lysine 14 of histone H3 on free histones while ADA acetylates 9,14, and 18 
and SAGA 23 in addition168. Ada2, Ada3, and Gcn5 form the catalytic core of these HAT 
complexes. Ada2 seems to potentiate the Gcn5 catalytic activity and Ada3 facilitates 
nucleosomal acetylation and expanded lysine specificity169. The SAGA complex also 
contains Spt gene products that are linked to TBPa function. This indicates the importance 
of histone acetylation during steps in transcription activation but also demonstrates that 
these modular complexes have multiple, independent functions in chromatin modification 
and TBP recruitment 166,170. Some subunits of HAT complexes also contribute to 
transcriptional function in targeting the complexes to promoters. For example, the yeast 
HAT complexes SAGA and NuA4 contact several yeast activators through their only 
common subunit Tra1171. A similar functionality is observed for TRRAPb in human 
complexes. MYST HATs are part of large complexes and their activity and specificity is 
modified by the other subunits, too. Their subunits differ from the elements present in 
complexes of HATs of the GNAT superfamily and indicate a role in epigenetics and cell 
proliferation control for MYST complexes. 
2.2.6 Non-histone-targets for acetylation 
Up to now, many HATs were shown to have other protein substrates in addition to 
histones. The first non-histone protein found to be a target for HAT acetylation was p53, a 
tumor suppressor and sequence specific DNA-binding transcription factor that is 
acetylated by p300/CBP and deacetylated by HDAC1c,172-174. Acetylation occurs at several 
lysine residues at the DNA binding regulatory domain enhancing DNA binding and 
thereby increasing activation of target genes. In addition, acetylation seems to promote 
protein stability due to protection of lysine residues that need to be ubiquitinated for 
degradation. Since then, a multitude of transcription factors as well as several other 
cellular and also viral proteins were shown to be substrates for lysine acetylation175. 
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2.2.6.1 Acetylated transcription factors 
YY1a has multiple roles including sequence specific DNA binding and activation as well 
as repression of transcription. While acetylation at the zinc-finger DNA binding domain 
decreases DNA binding activity, acetylation at the repression domain affects 
transcriptional activition176. 
High mobility group (HMG) proteins are known to bind to distorted DNA and induce 
bending in linear DNA. Members of different subfamilies can be acetylated by p300/CBP 
and/or PCAF. Acetylation yields different effects depending on the specific protein and the 
lysine residue modified including increased or decreased DNA binding affinity, increase in 
transcriptional activation as well as influence on nuclear localization177-180. 
STAT3b is a latent cytoplasmic transcription factor and the downstream effector of 
cytokine signaling pathways. Acetylation of STAT3 by p300/CBP enhances dimerization 
which is required for nuclear translocation as well as DNA binding and activation of target 
genes181,182.  
c-MYCc is known as an oncoprotein. Although acetylation sites targeted by PCAF/GCN5 
and Tip60 reside in the nuclear localization sequence and the leucine zipper domain, their 
modification has no effect on localization or interaction with proteins. Instead, acetylation 
seems to increase the stability of the protein by preventing ubiquitination of the lysine 
residues183. 
Nuclear receptors targeted by acetylation include the androgen receptor (AR) and the 
estrogen receptor α (ERα). Several HATs seem to be involved in the regulation of 
activation of AR184,185, while acetylation of ERα at the ligand binding domain regulates 
hormone sensitivity without affecting induction by MAPK signaling186 
Members of the GATA family of transcription factors associated with hematopoiesis are 
regulated by reversible acetylation, too. Acetylation increases transcriptional activation for 
GATA1, 2, and 3 as well as DNA binding for 1 and 2187-189. 
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EKLFa is also involved in hematopoiesis. EKLF is acetylated by p300/CBP at two specific 
lysine residues located in the transactivation domain and the zinc finger domain. 
Interestingly, transactivation requires acetylation of the first residue but does not influence 
DNA binding, but rather enhances recruitment of the SWI/SNF chromatin remodeling 
complex190,191. Acetylation of the second residue is associated with function of EKLF as a 
repressor and recruitment of co-repressors192. 
MyoDb is critical for skeletal myoblast differentiation. Acetylation by PCAF and 
p300/CBP regulates its activity by enhancing DNA binding and also facilitates binding to 
p300/CBP via its bromodomain193,194. 
Acetylated members of the E2F family promote proliferation. Modification by pCAF 
and/or p300/CBP of residues conserved in E2F 1, 2, and 3 at the DNA binding domain 
enhances DNA binding and, in consequence, transactivation. Furthermore, protein stability 
is increased by preventing ubiquitination195,196. Acetylated E2F1 is recruited to pro-
apoptotic genes as p73 which itself is a target for acetylation by p300. Again, acetylation 
prevents degradation and facilitates activation of other pro-apoptotic genes197,198. A direct 
binding partner of E2F, the tumor suppressor Rbc, is also acetylated by p300 and pCAF 
which seems to regulate differentiation-specific functions like cell cycle exit199. 
The function of NF-κBd is regulated by acetylation by p300/CBP. Controversial results are 
available on the influence of acetylation on DNA binding, transactivation, and interaction 
with IκBe,200-202 
HIF1f plays a role in adaption to changes in oxygen availability. Its stability is regulated by 
acetylation, but, in contrast to previous examples, in this case the modification promotes 
ubiquitination and subsequent proteasomal degradation203. 
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Finally, Smad7 acetylation by p300 increases its stability by protecting it from 
ubiquitination and degradation induced by TGFβ-signaling204. 
2.2.6.2 Other acetylated proteins 
Although the acetyltransferase responsible is not identified so far, acetylation of α-tubulin 
is known to play an important role in microtubule stability. While stable microtubules 
contain mainly acetylated α-tubulin, the opposite is true for dynamic microtubules205,206. 
Acetylation of importin-α by p300/CBP was shown to promote the interaction with 
importin-β, required for subsequent nuclear import of cargo proteins207. 
Ku70 is involved in the repair of double-strand breaks via the non-homologous end-joining 
DNA repair pathway and in regulation of apoptosis. Acetylation by PCAF and CBP was 
shown to impair the interaction of Ku70 with the pro-apoptotic factor Bax enabling 
initiation of apoptosis208. 
Acetylation of the molecular chaperone Hsp90a was shown to block its interaction with the 
glucocorticoid receptor (GR) preventing transcriptional activation by GR209,210. 
The adenoviral protein E1A is acetylated by p300/CBP and PCAF which was suggested to 
either influence interaction with the C-terminal binding protein resulting in transcriptional 
activation or localization by disrupting binding to importin-α3211,212. 
The small and large delta antigen of hepatitis delta virus both are targets for acetylation. 
Modification of the small antigen by p300 was shown to be required for its nuclear 
localization and viral RNA replication213. 
In conclusion, acetylation targets a multitude of non-histone proteins exerting various 
functions including regulation of DNA binding affinity, transcriptional activation, protein 
stability, and protein-protein interactions. In contrast to the widespread irreversible Nα-
terminal acetylation that occurs co-translationally, posttranslational acetylation of the ε-
amino-group of lysine residues is highly reversible. Thus, the non-histone acetylation 
targets are also substrates for deacetylating enzymes. In fact, most if not all histone 
deacetylases are able to deacetylate non-histone proteins. Together, the dynamic character 
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of lysine acetylation and the diversity of targeted proteins clearly suggest a role for 
acetylation beyond regulation of transcription. In fact, a general regulatory role for 
acetylation has been suggested similar to protein phosphorylation214. Anyway, this clearly 
demonstrates that prediction of a function as acetyltransferase by similarity to known 
HATs does not mean that the preferred substrate will be histones. Thus, extensive 
characterization of such a protein is indispensable. 
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3 Results and Discussion 
For the longest time, sequence analytics has been viewed as a support unit for research 
groups. The work was more or less request-based. With the development of more and 
more prediction tools and the availability of fully sequenced genomes, the field of 
sequence analytics developed a new dynamics. Genome-wide screens produced lots of 
predictions and interesting suggestions for new topics of research. Some results that fitted 
into the scientific orientation of research groups were picked up by them, but other 
promising topics, sometimes of vital interest for further improvement of sequence 
analytical tools, remained untouched. Thus, it was decided to build up a new biochemical 
unit integrated into the sequence analytics group. This unit was designated to develop 
biochemical assays for the experimental confirmation of sequence analytical predictions 
and to also start follow up projects on promising results. This is where I came in at the start 
of my diploma work. 
3.1 Development of an in vitro assay for investigation of the 
prenylation status of selected proteins 
Lipid posttranslational modifications have been a main topic in our group for a while now. 
Prediction tools for glycosylphosphatidylinositol anchors (GPI)215, protein N-
myristoylation109, and, last but not least, prenylation216 have been developed. Large scale 
application of the prenylation predictor and clustering of hits into protein families revealed 
several groups of predicted prenylation targets with no experimentally verified member. 
Since experimental testing of lipid anchor incorporation is laborious, annotation of lipid 
modifications by similarity to known targets has been used widely over the database, 
although it is known that the existence of the modifiable residue alone (a C-terminal 
cysteine for prenylation and N-terminal glycine for myristoylation) is not sufficient 
without a proper sequence environment. At the same time, consistent prediction of lipid 
anchoring within a protein family with the PrePS and NMT/MyPS tools together with an 
experimentally verified member can be considered a safe indication for the respective lipid 
modification among that group of targets. Therefore, it was of vital interest to test 
representative candidates from these new protein families. Using well established 
prenylation targets as a positive control, I developed an in vitro assay for analysis of the 
prenylation status of proteins217. It was based upon a previously described method utilizing 
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in vitro transcription and translation in the presence of radiolabeled lipid substrate218,219, 
but included several improvements. N-terminal GSTa-fusions of the cDNAs encoding the 
candidate proteins were amplified by polymerase chain reaction (PCR, see Materials and 
Methods: PCR) and used as template for coupled in vitro transcription/translation with 
rabbit reticulocyte lysate in the presence of ³H-labeled mevalonate (precursor for both 
types of prenylation, is converted to the final lipid substrates in the lysate), 
farnesylpyrophosphate (FPP), or geranylgeranylpyrophosphate (GGPP,). The translated 
protein was separated from other components of the lysate by GST-affinity purification 
and subjected to polyacrylamide gel electrophoresis under denaturing conditions (with 
sodium dodecylsulfate, SDS-PAGE). After electrotransfer of the protein to a nitrocellulose 
membrane, incorporated radioactive label was detected with a thin layer chromatography 
(TLC) linear analyzer followed by determination of total protein yield by a Western Blot 
with anti-GST-antibody (see Material and Methods: Biochemical techniques). 
This experimental setup has several advantages compared to the previous method. Without 
purification, the multitude of proteins in the rabbit reticulocyte lysate limits the amount of 
product analyzed in SDS-PAGE. The purification gives the opportunity to load the whole 
protein yield on a gel instead of just an aliquot. For proteins with weak expression, it is 
even possible to upscale the reaction volume to reach the desired amount of translation 
product. Furthermore, the purification step also reduces radioactive background increasing 
the signal to noise ratio. Thus, it is possible to detect prenylation of candidates that would 
have been classified as non-prenylated in the old setup. Another important improvement is 
the detection of incorporated radioactive label. While autoradiography or fluorography 
could take several weeks or even months, the TLC linear analyzer reduces the time effort 
to 20 minutes per lane. This makes it easier to repeat the experiments and optimize 
reaction conditions in reasonable time. Last but not least, the determination of the total 
protein yield is enhanced by the use of Western Blot. There is no need for a parallel 
reaction with [35S]methionine. It is possible to directly check the yield of the reaction with 
the prenyl anchors. Due to the GST-tag, the same antibody can be used for all candidates. 
This newly developed assay was used then successfully for the verification of selected 
candidate proteins from groups predicted to be subject to farnesylation with no 
                                                
a
 Glutathione-S-transferase 
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experimental evidence so far220. The human proteins RasD2, Rab28, the hypothetical 
protein FLJ32421, and C-terminal peptides of Prickle1 and 2 were shown to be 
farnesylated in vitro. Furthermore, the wild-type versions of the candidates as well as 
modified sequences with mutated prenylation site were expressed as fusions to GFP in 
HeLaa cells to demonstrate the importance of prenylation for localization of the proteins. 
3.2 Prenylation of bacterial proteins 
In addition to these proteins, a bacterial protein was investigated, too. Although the 
prediction of the prenylation of YopQ from Yersinia pestis (NP_995392) was in the 
twilight zone of the algorithm, the protein was of special interest. According to current 
knowledge, there are no prenyltransferases in bacteria. No protein from bacteria has been 
shown to be prenylated, too. For myristoylation, there are cases of proteins from 
pathogenic organisms utilizing the hosts NMT. Thus, it was tempting to speculate that the 
same could be true for prenylation. Unfortunately, it turned out that YopQ is no 
prenylation target. 
After my diploma work was finished, this topic was picked up again. Two more potential 
prenylation targets were selected for experimental investigation: an ankyrin repeat 
containing protein from Coxiella burnetii and a hypothetical protein from Legionella 
pneumophila. 
3.2.1 Coxiella burnetii 
A potential target for prenylation of a bacterial protein was identified in Coxiella burnetii, 
the cause of Q-fever. It is a hypothetical protein containing ankyrin repeats, hence it will 
be referred to as AnkRep protein for simplicity. Different versions of AnkRep are present 
in distinct strains. The respective proteins from the strains Dugway 7E9-12 
(ZP_01298590) and RSA331 (ZP_0130976.1) are almost identical differing only in a 
single residue far away from the C-terminal prenylation motif. In the strain RSA493, the 
gene is split into two open reading frames by an insertion resulting in a much shorter 
prenylation target corresponding to the C-terminus of the longer version (NP_819396.1). 
The N-terminal fragment carries no prenylation motif. The strain Graves harbors a C-
terminally truncated version lacking the prenylation motif. 
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Figure 3: Sequence alignment of ankyrin repeat containing protein variants from different strains of 
Coxiella burnetii 
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Application of the prenylation prediction suite on these proteins classified them as 
substrates for both farnesyltransferase (FT) and geranylgeranyltransferase (GGT) type 1 
(C-terminal peptide IKRVLAMPFEELMLETSIEEIKPSEDCLVM, FT score 0.165, P-
value 4.9e-03, GGT1 score 0.862, P-value 2,2e-03). The in vitro prenylation assay has 
been used to investigate the prenylation status of these protein variants. GST-fusions of the 
wildtype protein and a cysteine to alanine mutation (preventing prenylation) of the shortest 
version, the C-terminal fragment from RSA493, has been subjected to coupled 
transcription/translation in the presence of ³H-labeled mevalonic acid first to verify that the 
protein becomes isoprenylated, and subsequently with [³H]FPP and [³H]GGPP to identify 
which type of anchor is incorporated preferentially. The standard procedure was slightly 
modified. The elution buffer containing glutathione was not able to elute sufficient 
amounts of protein from the beads. Thus, the translated protein was eluted by addition of 
50 µl 2 x sample buffer and incubation at 95°C for 5 min. 
 
Figure 4: Western Blots and TLC scanning results for ankyrin repeat containing protein from Coxiella 
burnetii strain RSA493 
Western blot and corresponding scans from TLC linear analyzer of wild-type GST-fusion protein translated 
with [³H]mevalonate, the C246A-mutation with [³H]mevalonate, as well as wildtype with [³H]FPP and 
[³H]GGPP. 
It is clearly visible that the protein is farnesylated in vitro but, in contrast to the prediction, 
no geranylgeranylation was detected. Loss of the radioactive signal with the cysteine to 
alanine mutation demonstrated specific incorporation of the labeled isoprenoids. To rule 
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out influence of the additional amino acid sequence of the longer versions on the 
accessibility of the C-terminus for the farnesyltransferase, these proteins were also 
investigated. Both proteins from the strains Dugway 7E9-12 and RSA331 show clear and 
specific incorporation of a product of [³H]mevalonic acid. The prenylation motif is 
identical in these proteins, so the specificity of the isoprenoid type is expected to be the 
same. Therefore, the test with FPP and GGPP was skipped. The C-terminally truncated 
version from the strain Graves was included as an additional negative control. 
 
Figure 5: Western Blots and TLC scanning results for ankyrin repeat containing protein from Coxiella 
burnetii strains Dugway 7E9-12, RSA331 and Graves 
Western blot and corresponding scans from TLC linear analyzer of wild-type and C624A mutated GST-
fusion protein translated with [³H]mevalonate from the strains Dugway7E9-12 and RSA331 as well as 
wildtype GST-fusion protein from Graves. 
To check the potential influence of prenylation on the localization of the proteins in host 
cells, HeLa cells were transiently transfected with N-terminal GFP-fusions of the wildtype 
proteins and cysteine to alanine mutations (see Materials and Methods: Cell culture 
techniques). The cells were fixed, permeabilized, nuclei co-stained with 4′,6-Diamidino-2-
phenylindol (DAPI) and analyzed by fluorescence microscopy (see Materials and 
Methods: Fluorescence microscopy of GFP-constructs). A diffuse cytosolic localization 
was observed. All variants except for the N-terminally truncated protein from the strain 
RSA493 were clearly excluded from the nucleus. No difference in localization was found 
for the mutations. 
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Figure 6: Localization of N-terminal GFP-fusions of ankyrin repeat containing protein from Coxiella 
burnetii strains Dugway 7E9-12, RSA331, Graves and RSA493 in HeLa cells. 
Fluorescence microscopy of HeLa cells transiently transfected with N-terminal GFP-fusions. Nuclei co-
stained with DAPI are blue, GFP is green. The white scale bars represent a size of 10 µm.  
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3.2.2 Legionella pneumophila 
The second potential target for prenylation of a bacterial protein was identified in 
Legionella pneumophila. It is a hypothetical protein containing an F-box motif, thus it was 
named F-Box protein for convenience (YP_096532.1). The prenylation prediction suite 
predicts F-Box to be substrate for both farnesyltransferase and geranylgeranyltransferase 
type 1 (C-terminal peptide SQNLYINQDETIELFNKYTEEKTNNFCSIL, FT score 0.155, 
P-value 5.09e-03, GGT1 score 2.501, P-value 5.6e-04). Unfortunately, application of the 
in vitro prenylation assay on F-Box resulted in very low protein yields. A preliminary 
result indicated weak incorporation of a product of [³H]mevalonic acid into F-Box but, due 
to the problems with the protein yield, the result was not reproducible. All attempts to 
improve the result by skipping the purification to minimize losses or by increasing the 
reaction scale were not successful. Thus, it was also impossible to identify the nature of the 
isoprenoid incorporated into the translated protein. In conclusion, prenylation of the 
protein can not be ruled out, but could not be demonstrated free of doubt. 
As an alternative approach, the localization of N-terminal GFP-fusions of wildtype and 
cysteine to alanine mutation of F-Box in transiently transfected HeLa cells was 
investigated by fluorescence microscopy. The wildtype protein is clearly localized to some 
intracellular membrane compartments while the mutation shows a more diffuse 
distribution between intracellular membranes and the cytosol. This indicates that 
prenylation might be important for localization of F-Box, but of course this gives only 
indirect evidence for prenylation. 
 
Figure 7: Localization of N-terminal GFP-fusions of F-Box containing protein from Legionella 
pneumophila in HeLa cells. 
Fluorescence microscopy of HeLa cells transiently transfected with N-terminal GFP-fusions. The white scale 
bars represent a size of 10 µm.  
RESULTS AND DISCUSSION  
 45 
3.2.3 Discussion 
The in vitro prenylation assay clearly demonstrated that AnkRep from Coxiella burnetii is 
a substrate for farnesyltransferase. Localization studies using fluorescence microscopy of 
GFP-fusions showed no difference upon mutation of the prenylated cysteine. Thus, the 
protein might not become prenylated in HeLa cells, but it is also possible that other factors 
dominate the localization of AnkRep and the prenyl moiety is required for specific protein 
interactions or only in a certain context. For example, Ankyrin repeats are known to 
mediate protein interactions. Thus, an interaction partner could dictate the localization of 
AnkRep. For F-Box, in vitro prenylation was indicated by preliminary experiments but 
doubtless evidence for incorporation of an isoprenoid as well as identification of the type 
is missing. In this case, localization studies in HeLa cells suggest importance of the 
prenylation for subcellular membrane targeting. Of course, more data are needed to shed 
light on prenylation of bacterial proteins. For example, it will be important to address the 
question whether the proteins are secreted into host cells where they might get in contact 
with prenyltransferases. If they are not, the prenylation motifs could be an evolutionary 
curiosity that has arisen by chance because there is no negative selection against it in 
bacteria. If the proteins are accessible for a host prenyltransferase at least part of their 
lifetime, prenylation could be an important factor influencing localization and/or function. 
As a prerequisite for further experiments, an antibody was raised against a peptide 
common to all investigated variants of AnkRep. Unfortunately, it did not fulfill the 
requirements for the intended use. Nonetheless, both potential cases of prenylated bacterial 
proteins are still under investigation by other members of the lab. Recent results suggest 
secretion of the F-Box protein from Legionella pneumophila into the cytoplasm of 
macrophages (Hwei Ling Khor et al., 2008, to be published). Thus, prenylation of the 
protein in vivo seems plausible. 
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3.3 Influence of SNPs on prenylation 
Single nucleotide polymorphisms (SNPs) are DNA mutations that have managed to 
survive in the gene pool of a population to a certain degree. They account for 
approximately 90% of all variations in the human genome. They are not distributed 
equally over the genome, but occur in differing frequency in certain regions. SNPs can 
alter the amino acid sequence of the proteins encoded by the DNA. Therefore, they can 
account for different susceptibility of individuals for diseases and/or drugs. Since the 
recognition motifs for prenyltransferases require a certain type of amino acid at some 
positions and at least a certain pattern of physical properties in general, SNPs are able to 
influence those motifs. An SNP could destroy a prenylation site by mutation of the 
modified residue or of a residue in its environment and influence the type of anchor that is 
preferably attached or the accessibility for the prenyltransferases. Thus, SNPs can be 
involved in both generation and destruction of functional prenylation motifs. By 
application of the prenylation prediction suite, several cases of human proteins were 
identified where the score of the prediction is significantly altered by an SNP. The 
candidates selected for investigation were ALDH3B2a, BEX2b, UTP14Ac and the 
hypothetical protein FLJ20364.  
Name Accession C-terminal sequence FT-score GGT1-score 
ALDH3B2 NP_000686.2 TDWNQQLLRWGMGSQSCTLL -2.761 -2.051 
  TDWNQQLLRGGMGSQSCTLL -1.485 -0.638 
BEX2 NP_116010.1 RAVSTDPPHHDHHDEFCLMP -2.768 -12.860 
  RAVSTDPPHHDHHDEFCLMH -1.912 -15.262 
UTP14A NP_006640.2 RNPKRITTRHKKQLKKCSVD -2.692 -14.685 
  RNPKRITTRHKKQLKKCSVG -0.771 -10.423 
FLJ20364 NP_060255.2 SHPILYVSSKSTPETQCPQQ -1.870 -23.913 
  LHPILYVSSKSTPETQCPQQ -2.170 -24.213 
Table 1: Selected candidate proteins with SNPs in the prenylation motif predicted to influence 
prenylation 
                                                
a
 Aldehyde dehydrogenase 3 family, member 2 
b
 brain expressed X-linked 2 
c
 U3 small nucleolar ribonucleoprotein, homolog A 
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ALDH3B2 is suggested to become a better target for both FT and GGT1 after replacement 
of Trp375 with glycine. BEX2 and UTP14A show an improved score suggesting potential 
prenylation only for FT, and in the case of FLJ20364 the protein is predicted to be a worse 
farnesylation target due to the SNP. 
All candidates were investigated by the in vitro prenylation assay in both variants. No 
prenylation for either version was detected in the case of BEX2 and UTP14A. Preliminary 
results indicated incorporation of a product of [³H]mevalonic acid for FLJ20364, but no 
significant difference between the SNP variants. Finally, ALDH3B2 turned out to be an 
example of SNP-influenced prenylation. For ALDH3B2, N-terminal GST-fusions of the 
full-length protein did not yield a sufficient amount of protein. Therefore, it was decided to 
use a GST-fusion of a C-terminal peptide consisting of 25 amino acids instead since 
previous experiments had indicated better expression of shorter constructs. A significantly 
stronger signal from an incorporated product of [³H]mevalonic acid was detected with Gly 
at the position corresponding to amino acid 375 of the full protein compared to Trp. 
Consistent with the prediction, the protein was modified by both FPP and GGPP. 
Specificity was demonstrated by loss of the signal with a cysteine to alanine mutation. 
 
Figure 8: Western Blots and TLC scanning results for a C-terminal peptide of human ALDH3B2 
Western blot and corresponding scans from TLC linear analyzer of a fusion protein consisting of GST as 
well as residues 361 – 385 from the C-terminus of ALDH3B2 with a Trp at position 375 translated with 
[³H]mevalonate, [³H]FPP and [³H]GGPP, the W375G mutation with [³H]mevalonate and the C382A-
mutation with [³H]mevalonate. 
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Localization studies were performed with HeLa cells transiently transfected with N-
terminal GFP-fusions of both SNP variants of ALDH3B2, FLJ20364 and UTP14A. BEX2 
was not included as its prenylation was already ruled out by the in vitro experiments at that 
time point. No significant difference in localization was observed between the SNP 
variants in any case. 
 
Figure 9: Localization of N-terminal GFP-fusions of SNP variants of ALDH3B2, FLJ20364 and 
UTP14A in HeLa cells. 
Fluorescence microscopy of HeLa cells transiently transfected with N-terminal GFP-fusions. Nuclei co-
stained with DAPI are blue, GFP is green. The white scale bars represent a size of 10 µm. 
RESULTS AND DISCUSSION  
 49 
3.3.1 Discussion 
The case of ALDH3B2 clearly demonstrates that SNPs can influence prenylation motifs. 
Thus, they might participate in the genesis (or destruction) of such motifs in the course of 
evolution. Of course, this example only shows us a snapshot of the whole process. The 
modification with isoprenoids is only slightly enhanced by the mutation W375G and thus 
it is not surprising that no influence on subcellular localization was observed. Until now, 
ALDH3B2 remains a theoretical example for the influence of SNPs on prenylation. 
Whether this SNP has any relevance in vivo is still unclear. The members of the aldehyde 
dehydrogenase family play a role in detoxification of aldehydes generated by alcohol 
metabolism and lipid peroxidation. The cDNA of ALDH3B2 (also named ALDH8) is 
highly similar to ALDH7, but contains a termination codon corresponding to the seventh 
amino acid in the ALDH7 sequence. Thus, ALDH3B2 is either a non-processed 
pseudogene or a functional gene if the stop codon is skipped or suppressed221. The mRNA 
has been shown to be expressed specifically in salivary gland, but protein expression has 
not been investigated so far. To address this question, an antibody has been raised against a 
peptide specific for ALDH3B2. Unfortunately, the antibody was not good enough to use it 
for testing expression of ALDH3B2 in tissue samples. A commercial antibody available 
for ALDH3B2 did not meet the requirements, too. Furthermore, it might be necessary to 
generate an antibody specific for ALDH7 in addition to ensure maximum specificity. In 
conclusion, investigation of the expression status of ALDH3B2 seems not to be an easy 
task, but the project is still continued by other members of the lab. 
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3.4 Experimental investigation of protein N-myristoylation 
According to our focus on lipid posttranslational modifications, a sequence analytical tool 
for the prediction of protein N-myristoylation was developed in our group109. Another 
group at the institute showed interest in several potential myristoylation targets in 
Drosophila melanogaster, hence it was decided to try to adapt our in vitro assay for the 
investigation of protein N-myristoylation. In addition, our interest in “paradox”-targets, 
proteins showing a motif for a lipid posttranslational modification in a context where it is 
usually not found like the bacterial prenylation targets, prompted us to investigate a 
transcription factor predicted to be myristoylated. 
3.4.1 Adaption of the assay for the detection of myristoylation 
Since the main application of an in vitro myristoylation assay was the investigation of the 
candidates from fly, it was decided to use a positive control from this organism for setting 
up the assay. The perfect candidate for this purpose was igloo-La (AAB32065.1). This 
protein was shown to be modified with myristic acid using in vitro transcription and 
translation, demonstrating that sufficient NMT activity is present in rabbit reticulocyte 
lysate222. Several modifications to the experimental setup used for the detection of 
prenylation were necessary. First of all, a C-terminal GST-tag had to be used since 
myristoylation occurs at the N-terminus. Due to the lack of commercially available vectors 
with C-terminal GST-Tag, a self-constructed plasmid was used (GST was amplified from 
pGEX-5X-1 and cloned into a pSK+-vector, the construct will be referred to as C-GEX). 
As radioactively labeled lipid substrate, [³H]myristic acid was used. Furthermore, the 
reaction time had to be changed. While an incubation time of four hours (at least) yielded 
best results for prenylation, a reduction to two hours gave the best results with 
myristoylation. Longer incubation times did not increase the incorporation of radioactive 
label, but reduced the total protein yield. Since N-myristoylation occurs at the N-terminus 
and usually as a co-translational modification, it seems plausible that less time is needed 
than for prenylation which requires the C-terminus to leave the ribosome to be accessible 
for the prenyltransferase. The decrease of protein yield over time seems to be caused by 
adsorption of the hydrophobic myristoylated proteins to the reaction tubes. This effect was 
already observed with prenylated proteins and posed even more problems with the more 
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 Invertebrate GAP-43 like, the L symbolizes the larger isoform 
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hydrophobic myristoylated proteins. Therefore, also the purification step introduced 
successfully for the prenylated proteins had to be skipped in the myristoylation assay. No 
conditions were found that allowed elution of a satisfying amount of GST-fusion protein 
from the beads, even with increased glutathione concentration. Elution with SDS-PAGE 
sample buffer was also tested but yielded in co-elution of a lot of background radioactivity 
rendering the purification rather useless. Thus the direct application of unpurified reaction 
mix on the acrylamide gel turned out to be the best solution. 
After elaboration of all necessary modifications, application of the final assay on igloo-L 
demonstrated functionality of the assay. The radioactivity measurement yielded a peak at a 
molecular weight corresponding to the band in the Western blot of igloo-L-GST, leaving 
no doubt about the incorporation of myristic acid. In contrast, the G2A mutant protein, 
which served as a negative control, gave no signal exceeding the background noise 
although the protein yield in the Western blot was even larger (another hint for loss of 
myristoylated protein). In conclusion, it was possible to apply at least some of the positive 
aspects of the improved assay also for protein N-myristoylation. 
 
Figure 10: Western Blots and TLC scanning results for igloo-L 
Western blot and corresponding scans from TLC linear analyzer of wild-type and G2A mutated C-terminal 
GST-fusions translated with [³H]myristate. 
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3.4.2 In vitro myristoylation status of predicted myristoylation 
targets from Drosophila melanogaster 
The D. m. numb protein is important in the development of the nervous system. 
Asymmetric distribution of the protein during mitosis is associated with cell polarity and, 
in consequence, determination of cell fate. During asymmetric cell division of the sensory 
organ precursor, numb is segregated to only one daughter cell where it antagonizes Notch 
signaling223,224. Two isoforms of the protein are known named numb-A (AAA28730.1) 
and B. Numb-B is an N-terminal truncation of isoform A lacking 41 residues including the 
glycine obligatory for myristoylation. The N-terminal sequence of numb-A 
(MGNSSSHTHEPLERGFTR) is predicted as a reliable myristoylation site (score 0.949, 
P-value 1.75e-03). C-terminal GST-fusions of wildtype and G2A mutated numb-A were 
transcribed and translated in the presence of [³H]myristic acid. The proteins in the reaction 
mix were resolved by SDS-PAGE, transferred to a nitrocellulose membrane and analyzed 
by scanning with a TLC linear analyzer and Western Blot with anti-GST HRP-conjugated 
antibody. A clear signal of incorporated myristate is detected for the wildtype protein, but 
missing for the G2A mutant protein, indicating specific modification of the N-terminal 
glycine with myristic acid. 
 
Figure 11: Western Blots and TLC scanning results for numb-A 
Western blot and corresponding scans from TLC linear analyzer of wild-type and G2A mutated C-terminal 
GST-fusions translated with [³H]myristate. 
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Par-1 is a serine/threonine kinase225 expected to play multiple roles in Drosophila 
development. It is involved in oocyte fate determination and maintenance by establishing 
anterior-posterior polarity of the oocyte. The localization of Par-1 changes during oocyte 
development226-228. Consistent with multiple roles, fifteen different splice variants of Par-1 
are described. Three different N-terminal sequences are present in those variants, but only 
one of them is a potential target for myristoylation. The sequence of this N-terminus 
(MGQTSSHRQM HHSSNNNN) is predicted as a reliable myristoylation site (score 3.596, 
P-value 2.46e-05). For convenience, the shortest protein harboring the myristoylation 
motif, Par-1 isoform Q (AAM75016.1), was chosen for investigation. Specific 
modification of the N-terminal glycine of Par-1 isoform Q was verified by application of 
the in vitro myristoylation assay on wildtype and G2A mutated C-terminal GST-fusions. 
 
Figure 12: Western Blots and TLC scanning results for Par-1 isoform Q 
Western blot and corresponding scans from TLC linear analyzer of wild-type and G2A mutated C-terminal 
GST-fusions translated with [³H]myristate. 
The third protein from Drosophila melanogaster selected for experimental investigation is 
neuralized (neur). Similar to numb, it plays a role in determining cell fate in development 
of the nervous system. While numb is segregated to one daughter cell of the sensory organ 
precursor inhibiting Notch signaling there, neur is inherited by the other daughter cell. In 
contrast to numb, Notch signaling is activated by neur229. Four different transcript variants 
are described for neur designated A, B, C, and D. Isoforms A and B as well as C and D are 
identical except for a glutamine which is present at position 672 in isoform A and in 
position 590 in isoform C but is missing in isoforms B and D. Since, according to current 
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knowledge, only the first 17 amino acids of a protein are of relevance for its 
myristoylation, only isoforms B (AAK93411.1) and C (AAO41451.1) were investigated. 
Neuralized B and C differ in their N-terminal sequence. While both of them harbor a 
glycine at position 2, only neur-C is predicted as a reliable myristoylation target (N-
terminal sequence MGQSAGKIVRRSPSSCPG, score 1.407, P-value 9.69e-04) while 
isoform B is rejected by the predictor due to several negative physical property terms (N-
terminal sequence MGLSDIPANYMQGSHPHL, score -12.466, P-value 4.75e-01). The 
hydrophobic leucine residue at position 3, a negative charge at position 5, and the 
hydrophobic residues with reduced backbone flexibility at positions 6 and 7 (isoleucine 
and proline) do not fulfill the requirements of the substrate binding pocket of animal NMT. 
In agreement with the predictions, neither the wildtype protein of neur-B nor the G2A 
mutant negative control show incorporation of ³H-labeled myristic acid in the in vitro 
assay, although a satisfying total protein yield is detected. In contrast, neur-C wildtype 
protein yields a clear radioactive signal while the G2A mutant protein gives no signal 
above background noise at comparable protein yield. 
 
Figure 13: Western Blots and TLC scanning results for neuralized-B and C 
Western blot and corresponding scans from TLC linear analyzer of wild-type and G2A mutated C-terminal 
GST-fusions translated with [³H]myristate. As isoforms A and B as well as C and D are almost identical, the 
results can be expected to reflect the myristoylation status of all four isoforms. The band corresponding to 
the calculated molecular weight of neur-B is marked with an arrow. 
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3.4.3 Localization in fly embryos 
To investigate the influence of myristoylation on the localization of the proteins in vivo, 
transgenic flies were generated expressing C-terminally myc-tagged constructs. These 
experiments were carried out in cooperation with the lab of Jürgen Knoblich (Institute for 
molecular biotechnology, IMBA). Fluorescence microscopy of embryonic epithelial cells 
revealed cortical localization of wildtype igloo-L while the G2A mutant was 
predominately cytosolic. For numb-A, the mutant still shows cortical localization but 
seems to be partially delocalized to the cytoplasm. Both wildtype and G2A mutant neur-B 
are localized cortical, consistent with the finding that neur-B is not myristoylated in vitro. 
Obviously, other factors determine the localization of neur-B. Unfortunately, no flies 
yielding satisfying results were generated for neur-C. For Par-1 isoform Q, cortical 
localization is clearly disrupted by mutation of the myristoylated glycine residue. 
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Figure 14: Localization of igloo-L, numb-A, neur-B and Par-1 isoform Q in embryonic fly epithelium 
Fluorescence microscopy of embryonic fly epithelium expressing C-terminal myc-fusions of wildtype and 
G2A mutant candidate proteins stained in green. DNA is stained in blue and the cortical marker Miranda in 
red. 
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3.4.4 Myristoylation of proteins homologous to neuralized from 
mouse 
Only two of the isoforms of neur in Drosophila are myristoylated in vitro¸ although all of 
them harbor a glycine at position 2. Other differences in the N-terminal sequences account 
for the selective myristoylation of isoform C and D. To get a more complete picture of 
selective myristoylation of neur isoforms, two homologous proteins from Mus musculus 
(M. m.), neuralized-like 1 (AAH58386.1) and 2 (AAK97495.1), were chosen for 
investigation additionally. Like the proteins from Drosophila, they are highly identical. In 
fact, except for the very N-terminal sequence, they are identical in all but one residue. In 
contrast to the proteins from Drosophila, reliable myristoylation sites are predicted for both 
isoforms (neuralized-like 1 with the N-terminal sequence MGNNFSSVSSLQRGNPSR 
with score 2.348, P-value 2.40e-04 and neuralized-like 2 with the N-terminal sequence 
MGGQITRNTIHDSIGGSF with score 1.124, P-value 1.141E-03). Both versions were 
investigated with the in vitro myristoylation assay. Unfortunately, no satisfying protein 
yields were produced with the GST-fusions of the full-length proteins. Since shorter 
sequences often tend to give better protein yields with in vitro transcription/translation, it 
was decided to use N-terminal fragments representing the first 262 amino acids of 
neuralized-like 1 and the first 245 residues of neuralized-like 2, respectively. 
 
Figure 15: Western Blots and TLC scanning results for mouse neuralized isoforms 
Western blot and corresponding scans from TLC linear analyzer of wild-type and G2A mutated C-terminal 
GST-fusions representing the first 262 and 245 amino acids of the mouse neuralized isoforms translated with 
[³H]myristate. 
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With these truncations, glycine-dependent incorporation of myristic acid into both versions 
was clearly demonstrated. 
To address the effect of myristoylation on the localization of the proteins, too, C-terminal 
GFP fusions of the full-length sequences were transiently transfected in mouse 3T3a cells. 
Fluorescence microscopy revealed membrane attachment of both wildtype versions while 
the G2A mutations were predominately present in the nucleus. Our result is in agreement 
with data in a recently published work on neuralized-like 1230. 
 
Figure 16: Localization of mouse neuralized isoforms in 3T3 cells 
Fluorescence microscopy of mouse fibroblasts (3T3) expressing C-terminal GFP-fusions of wildtype and 
G2A mutant mouse neuralized isoforms. DNA is stained in blue. 
                                                
a
 3-day transfer, inoculum 3 x 105 cells 
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3.4.5 Discussion 
The investigated candidates from Drosophila melanogaster, numb, Par-1, and neuralized, 
are three examples of proteins expressed in different isoforms. In all three cases, only 
some, but not all, different versions are subject to myristoylation in vitro. It is likely that 
the selective myristoylation of only a subpopulation of the proteins might be of importance 
in vivo. Different isoforms could exert different functions or a similar function but at 
different locations. Unfortunately, very little is known on the functional differences of the 
isoforms. Some phenotype rescue and localization experiments concerning Par-1 already 
gave a first hint226,231, and it will be of growing importance in the future to separately 
investigate the different isoforms of a protein. Summing up the results gathered with the in 
vitro myristoylation assay on proteins from both fly and mouse, all predictions were 
verified experimentally indicating that the predictor is capable of distinguishing between 
the ability of N-terminal glycines in different context to become modified by NMT or not. 
The localization studies underscore the importance of myristoylation for targeting of the 
investigated proteins. In the case of igloo-L and Par-1 Q as well as the mouse neuralized 
proteins, mutation of the site of attachment of the myristoyl moiety drastically changes the 
localization of the proteins. The smaller effect observed for numb-A indicates that several 
other membrane attachment factors might contribute to the correct targeting of the protein 
compensating the loss of myristoylation to some degree. As already discussed, 
myristoylation is believed to provide only transient interaction with membranes which 
have to be enhanced by other MAFs for stable membrane attachment. Numb could be part 
of a protein complex that is able to bind membranes without myristoylation of numb, too. 
This assumption remains to be verified experimentally. The cortical localization of D. m. 
neur-B seems to be determined by other factors, too, as it is not influenced by mutation of 
the N-terminal glycine. 
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3.5 NFAT5-A – a myristoylated transcription factor? 
Two common mechanisms for regulation of translocation of transcription factors to the 
nucleus are widely accepted in the scientific community. One type are cytosolic 
transcription factors with the nuclear localization signal (NLS) masked by binding of an 
inhibitor protein like in the case of NF-κB. Upon activation of the appropriate signaling 
pathway, the inhibitor protein IκB is removed from the transcription factor exposing the 
NLS that guides translocation into the nucleus232. The second type of transcription factors 
has their NLS exposed all the time but is prevented from entering the nucleus by 
membrane anchorage via transmembrane regions like SREBPa which is attached to the 
endoplasmatic reticulum (ER). Upon activation, proteolytic cleavage releases the 
transcription factor from the membrane enabling it to enter the nucleus233. As membrane 
attachment is not only possible via transmembrane regions, an in silico screen was carried 
out to look for transcription factors predicted to be substrates for lipid modifications. As 
the most promising candidate derived from the screen, the human transcription factor 
NFAT5-Ab (NP_619728) was chosen for experimental investigation. Again, this is an 
example of selective modification of proteins isoforms. The three variants of NFAT5 
named A, B, and C (b: NP_619727, c: NP_006590) differ only in their N-termini where 
only the shortest isoform a harbors a glycine residue in the context required for 
myristoylation. 
Expression of sufficient amounts of the full-length protein (158 kDa) fused to a C-terminal 
GST-tag was not achieved, hence it was decided to use a truncation representing the first 
541 amino acids of NFAT5-A. The in vitro myristoylation assay indicated covalent 
attachment of radioactive myristate at the wild-type fusion protein, whereas the G2A 
mutated version yielded no radioactive signal despite similar protein yield. 
                                                
a
 Sterol regulatory element binding protein 
b
 Nuclear factor of activated T-cells 5, isoform a 
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Figure 17: Western Blots and TLC scanning results for human NFAT5-A 
Western blot and corresponding scans from TLC linear analyzer of wild-type and G2A mutated C-terminal 
GST-fusions representing the first 541 amino acids of human NFAT5-A translated with [³H]myristate. 
To check the impact of myristoylation on the localization of NFAT5-A, HeLa cells were 
transiently transfected with C-terminal GFP-fusions of wildtype and G2A mutated 
NFAT5-A. As expected, the wildtype protein accumulated at intracellular membranes 
while the mutated version that can not be myristoylated anymore is found predominately in 
the nucleus. 
 
Figure 18: Localization of human NFAT5-A in HeLa cells 
Fluorescence microscopy of HeLa cells transiently transfected with C-terminal GFP-fusions of wildtype and 
G2A mutant human NFAT5-A. DNA is stained in blue. 
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3.5.1 Discussion 
NFAT5-A is the first example of a lipid modified transcription factor. Myristoylation has 
been demonstrated in vitro, and the relevance of the lipid anchor for intracellular 
localization has shown by fluorescence microscopy of GFP-fusions. This finding could 
represent a new mechanism for the regulation of nuclear import of transcription factors. 
Membrane attachment mediated by the myristoyl anchor seems to be required to prevent 
NFAT5-A from entering the nucleus. Different options come to mind for a mechanism 
including myristoylation of the transcription factor. As myristic acid is not able to provide 
stable membrane binding, other factors could enhance the membrane interaction of 
NFAT5-A. A cysteine residue is present at position 5 providing a potential site for 
palmitoylation. If NFAT5-A is indeed stably associated to the membrane via double 
acylation, it has to be released upon activation. This could be achieved by proteolytic 
cleavage in analogy to other membrane attached transcription factors. Alternatively, de-
palmitoylation could weaken the membrane interaction facilitating detachment from the 
membrane. This could be enough to enable the myristoylated protein to enter the nucleus. 
In theory, one could also think of a switch mechanism where the myristoyl moiety is 
buried in a hydrophobic pocket of the protein after a conformational change. 
If NFAT5-A is not palmitoylated to achieve stable membrane binding, the myristoyl 
anchor could act as brake delaying nuclear import. The other isoforms B and C are no 
substrates for myristoylation, but are kept outside the nucleus, too. A mechanism with 
active nuclear export of NFAT5 has been suggested234. This mechanism could also apply 
for NFAT5-A, but with the addition that nuclear import upon activation is delayed for 
NFAT5-A due to transient membrane interactions mediated by myristoylation. In this 
model, isoforms b and c would represent kind of a fast response to an activating stimulus 
while NFAT5-A could mediate a slower long-term response. Further experiments will be 
required to elucidate the impact of myristoylation on the function of NFAT5-A and a 
potential mechanism for release of lipid-anchored transcription factors. My lab colleague 
Michaela Sammer, who also participated in the localization experiments presented in this 
work, currently continues the investigation of NFAT5. 
RESULTS AND DISCUSSION  
 63 
3.6 Mec-17 – an uncharacterized protein predicted to act as N-
acetyltransferase 
Mec-17 (NP_501337) was identified originally as a gene expressed in Caenorhabditis 
elegans (C. e.) touch receptor neurons235. The gene product seems to be required for 
maintained differentiation of these neurons. In mec-17 deficient animals, expression of 
mec-3, which seems to be a major determinant for differentiation, is lost during 
development236,237. A BLASTa search was carried out to search for homologous proteins in 
other species. In the course of analysis of conserved segments, the sequence stretch Q-R-
X-G-X-G was found almost identical in all homologues and identified as part of motif A in 
histone acetyltransferases from the GNAT superfamily. This motif was well known from 
previous work in our lab with Eco1238 and is part of the acetyl-CoA binding site. 
Subsequent alignment with other members of the GNAT superfamily revealed additional 
similarities in the unique motifs B, C, and D, too. Taken together, significant conservation 
was found including a common hydrophobic pattern, secondary structure (predicted for 
mec-17), and functional residues. Thus, an enzymatic function as N-acetyltransferase was 
suggested. This would provide a plausible explanation for the influence of mec-17 on the 
expression of others proteins as acetylation of histone tails or transcription factors is well 
known to be involved in regulation of transcription. The homologues mec-17 and 
w06b11.1 (NP_508981) from C. e., 2610110G12Rik (BAC25866) from Mus musculus  
(M. m.) and c6orf134 (AAH25755) from Homo sapiens (H. s.) were selected for 
experimental investigation. 
                                                
a
 Basic Local Alignment Search Tool 
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Figure 19: Alignment of mec-17 homologues with GNAT superfamily members 
GNAT family members: AANAT (Ovis aries) Arylalkylamine N-acetyltransferase, Hat1 (Saccharomyces 
cerevisiae), Gcn5 (Homo sapiens), PCAF (Homo sapiens), AAC-3 (Pseudomonas aeruginosa) 
aminoglycoside N-acetyltransferase, AAC-6 (Enterobacter cloaca), YP-256739.1 (Sulfolobus acidocaldarius 
DSM 639) Elp3 related protein; homologous genes of mec-17: SJCHGC00609 (Schistosoma japonicum), 
c6orf134 (Homo sapiens), 2610110G12Rik (Mus musculus), LOC406389 (Danio rerio), EAN95981.1 
(Trypanosoma cruzi), CAJ05171.1 (Leishmania major), CG17003-PA (Drosophila melanogaster), wo6b11.1 
(Caenorhabditis elegans) 
3.6.1 Recapitulation of previous results on mec-17 function 
The putative N-acetyltransferases were recombinantly expressed as GST-fusions in 
Escherichia coli (E. coli) and purified using affinity chromatography. An enzyme linked 
immunosorbent assay (ELISA) with immobilized histone tail peptides was used to test the 
HAT activity of the recombinant proteins in vitro. These experiments revealed intrinsic 
acetyltransferase activity for all four tested proteins, albeit the activity was weak compared 
to the known HAT PCAF as a positive control. Furthermore, mutation of conserved 
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residues in the acetyl-CoA binding site did not significantly reduce the activity, although 
the initial signals might have been too low to detect a partial loss of activity. Several 
explanations are possible for these results. Typically, histone acetyltransferases are part of 
multisubunit protein complexes. The other members of such complexes were shown to 
modulate both activity and substrate specificity of the HATs. Thus, the recombinant 
proteins might show only partial activity or insufficient substrate recognition. 
Alternatively, missing posttranslational modifications might cause reduced activity in the 
ELISA assay. Modifications of the enzymes or of the substrate peptides could be required 
for full activity as recognition of histone tails by modifying enzymes is strongly influenced 
by the PTMs already present on the histone tails. As a third explanation, histones might 
not be the preferred substrate for the putative acetyltransferases after all. Preliminary 
localization experiments with the homologues from mouse in N2Aa cells and from human 
in HeLa cells, respectively, indicated localization of the proteins outside the nucleus 
supporting the assumption that non-histone proteins might be the true substrate. To address 
these questions, it would really help a lot to identify the proteins interacting with the 
homologues of mec-17. Due to the lack of experience and equipment for work with C. e. in 
our lab, it was decided to focus on the homolog from mouse, 2610110G12Rik, for further 
experiments. For simplicity, it will be referred to as M. m. mec-17 from now. 
3.6.2 Expression profile of mec-17 
According to RNA expression profiles, M. m. mec-17 is expressed strongest in the brain. 
To check the expression on the protein level, a Western Blot with total protein lysates from 
various tissues was done with a specific antibody raised against the first 194 residues of 
mec-17 (see Materials and Methods: Protein expression profile of M. m. mec-17). Indeed, 
of all tissues examined, prominent expression of mec-17 was only detected in the brain. 
Thus, the RNA profile seems to give a representative picture of the protein expression of 
mec17. 
                                                
a
 Murine neuroblastoma 
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Figure 20: Transcription profile of 2610110G12Rik from GNF Symatlas 
 
Figure 21: Mouse major tissue Western Blot with antibody directed against mec-17 
The expected size of mec-17 is marked by the arrow. The band marked with an asterisk seems to be caused 
by a cross-reaction of the antibody. 
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3.6.3 Yeast-2-hybrid screen 
To look for proteins interacting with mec-17, it was decided to carry out a yeast-two-
hybrid screen. Mec-17 is primarily expressed in the brain as demonstrated above. Thus, a 
mouse brain cDNA library was used as prey. Since the library was cloned into a vector of 
the LexA-system and the other components were available at the institute, this system was 
chosen for the screen. The LexA-system uses a fusion of the protein of interest to the 
bacterial protein LexA as bait and a library fused to the transcriptional activator B42 as 
prey. Expression of the library is induced by galactose. An interaction reconstitutes a 
functional transcription factor binding to LexA-operators and activating transcription of 
downstream sequences. LEU2 is integrated as a reporter gene into the yeast strain 
providing growth selection, and a reporter plasmid carrying LacZ enables visual selection. 
A fusion of LexA to the yeast transcription factor GAL4 is used as positive control and a 
fusion to the D. m. protein bicoid as a negative control (see Material and Methods: Yeast 
2-hybrid screen). 
First of all, the library was amplified by transformation into E. coli and subsequent 
plasmid preparation from the bacteria to produce sufficient amounts of DNA (see Material 
and Methods: Amplification of the cDNA library). 
To test the autoactivation potential of the bait LexA-mec-17, bait and reporter plasmid 
were co-transformed into the yeast strain EGY48 and plated onto selective medium. In 
addition, positive and negative controls were included. The yeast containing the bait 
plasmid was able to grow on medium selective for the plasmids, but not on medium 
requiring activation of the LEU2 reporter gene. A β-galactosidase filter assay was done 
additionally (see Materials and Methods: β-galactosidase filter assay). The positive control 
colonies turned blue after 5 – 10 min, the bait showed a faint blue color after 45 min, and 
the negative control was still white after 60 min. It was decided that the autoactivation 
potential of LexA-mec-17 is low enough for the screen. 
Expression of the fusion protein was checked by Western Blot with anti LexA-antibody 
(1:20.000) from a total protein lysate of the transformed yeast and found satisfying (see 
Material and Methods: Total protein lysate from yeast). The ability of the fusion protein to 
enter the nucleus and bind to LexA-operators was tested by a repression assay. In this 
assay, a test plasmid harboring a constitutively active promoter preceding LexA operators 
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and the lacZ gene is co-transformed with the bait. When the bait protein is expressed, 
enters the nucleus, and binds to the LexA-operators, transcription of the reporter gene is 
blocked. Again, transcription of the reporter gene was tested by a β-galactosidase filter 
assay. Colonies expressing LexA, LexA-mec-17, or LexA-bicoid turned slower blue than 
colonies harboring only the test plasmid suggesting that the bait is able to enter the nucleus 
and bind the LexA operators. 
For the screen, large scale transformation of the library is necessary. As transformation 
into yeast already carrying the bait and reporter plasmid failed to work with sufficient 
efficiency, it was done into yeast carrying only the bait plasmid (see Materials and 
Methods: Large scale yeast transformation). The transformed yeast was plated onto 
medium inducing expression of the library and selective for the plasmids and also for 
activation of the reporter gene due to interaction of the proteins. Transformation efficiency 
was monitored by plating a serial dilution on medium selective only for the plasmids. A 
total yield of 14 million colonies was measured for the screen. After 3 days, 164 colonies 
growing on –Leu were picked. Seven clones did not grow anymore after transfer to a new 
plate, and 5 clones could also grow on -Leu without induction of the library exposing them 
as false positives. These clones were eliminated. From the remaining 152 clones, plasmid 
DNA was isolated (see Materials and Methods: Plasmid isolation from yeast), transformed 
into a bacterial strain (KC8) allowing selection for the library plasmid by electroporation 
and plated onto minimal medium selective for the library plasmid. Plasmid DNA was 
isolated from the bacteria (4 minipreps for each clone) and inserts were checked by 
restriction digestion. Only 52 clones yielding the same pattern for all four minipreps were 
further characterized. These plasmids were retransformed into the yeast strain carrying bait 
and reporter plasmid. As a selectivity control, the same was done with the empty bait 
plasmid expressing only LexA instead of LexA-mec-17. Growth selection with and 
without induction of the library was repeated and, in addition, visual selection was done by 
a β-galactosidase filter assay (see Materials and Methods: Liquid β-galactosidase assay). 
46 clones passed all tests. The plasmid inserts were sequenced and the results blasted 
against the mouse mRNA database. Only protein coding sequences creating an in-frame 
fusion with the activation domain were considered resulting in 11 potential interaction 
partners for mec17. A quantitative liquid β-galactosidase assay was done with these clones 
to estimate the strength of the interaction. LexA-mec17 alone was tested as an 
autoactivation control, a LexA-GAL4 fusion as positive control, and LexA-bicoid as 
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negative control. The empty library plasmid pJG4-5 was tested in combination with LexA-
mec17 to exclude interaction of mec-17 with the activation domain. In addition, all 
candidates were tested also without inducing expression of the interaction partner as well 
as in combination with LexA alone instead of LexA-mec17 to exclude interaction of the 
candidates with LexA. All these controls yielded results in the same order of magnitude as 
the negative control. 
LexA-mec17 (autoactivation control)  0,86 +/- 0,13 units 
LexA-GAL4 (positive control)  2877 +/- 1570,1 units 
LexA-bicoid (negative control)  1,21 +/- 0,18 units 
pJG4-5 (specificity control) + LexA-mec17 1,26 +/- 0,31 units 
Psmc5a (NP_032976) + LexA-mec17 450,95 +/- 268,68 units 
Rps27ab (expressed as fusion to 
ubiquitin, NP_001029037) + LexA-mec17 355,2 +/- 165,02 units 
Epb4.1l3c (NP_038841) + LexA-mec17 308,91 +/- 91,47 units 
Kif5Bd (NP_032474) + LexA-mec17 293,42 +/- 59,24 units 
Immte, Mitofilin (NP_083949) + LexA-mec17 266,09 +/- 50,28 units 
6330407J23Rik (NP_080414) + LexA-mec17 181,17 +/- 154,32 units 
Dctn1f (NP_031861) + LexA-mec17 162,05 +/- 43,5 units 
mRASg (NP_032650) + LexA-mec17 139,02 +/- 27,68 units 
Kctd13h (NP_766335) + LexA-mec17 107,06 +/- 85,48 units 
Kif2Ai (NP_032468) + LexA-mec17 83,15 +/- 30,15 units 
Spnb2j (NP_787030) + LexA-mec17 50,78 +/- 9,1 units 
Table 2: β-galactosidase activity of clones interacting with mec-17 
                                                
a
 Proteasome 26S subunit, ATPase, 5 
b
 Ribosomal protein S27a 
c
 Erythrocyte protein band 4.1 like 3 
d
 Kinesin family member 5B 
e
 Inner membrane protein, mitochondrial 
f
 Dynactin1 
g
 Muscle and microspikes RAS 
h
 Potassium channel tetramerization doman containing 13 
i
 Kinesin family member 2A 
j
 Spectrin β2 
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Figure 22: Column diagram of β-galactosidase activity 
3.6.4 Co-Immunoprecipitation of mec-17 with interaction partners 
To further strengthen the data from the screen, it was tried to co-precipitate mec-17 and its 
interaction partners from N2A cells. Therefore, cDNAs encoding the full-length sequences 
of the candidates identified were gathered. Unfortunately, no cDNAs representing the 
desired sequences of Dctn1, 6330407J23Rik, Kif2A, and Spnb2 were available. The others 
were cloned as N-terminal fusions with a FLAG-HA-Tag and co-transfected with an 
untagged mec-17 expression clone into N2A cells. One day after transfection, the cells 
were lysed and mec-17 precipitated with specific antibody bound to beads. After washing, 
proteins were eluted with sample buffer and resolved by SDS-PAGE. Proteins were 
detected by Western Blot with anti-mec-17 antibody for precipitated mec-17 and anti-HA-
HRP-conjugate for co-precipitated interacting proteins (see Materials and Methods: Co-
Immunoprecipitation). Immt, Kif5B, and Rps27a could not be detected in the lysate prior 
to precipitation and seem to be not expressed. Epb4.1l3, Psmc5, and mRAS were 
expressed, but not detected after precipitation. For Kctd13, co-precipitation with mec-17 
was clearly demonstrated. As a control, the same procedure was done without antibody 
from the same lysate to exclude unspecific binding of Kctd13 to the beads. This 
experiment shows that Kctd13 is only precipitated together with mec-17 and not alone. 
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Figure 23: Co-IP of Kctd13 with mec-17 from transiently transfected N2A cells 
3.6.5 Discussion 
Several potential interaction partners of mec-17 have been isolated. Only one interaction 
could be confirmed by co-immunoprecipitation (co-IP), but this does not rule out a 
potential functional linkage to the other proteins. A co-IP requires a relatively stable 
association over the time needed for the experimental procedure. Thus, some of the 
proteins found in the yeast 2-hybrid screen could be substrates for mec-17 that interact 
with the enzyme only transiently. 
Unfortunately, not much is known about the one confirmed interaction partner of mec-17. 
Kctd13 has been shown to interact with the small subunit of DNA polymerase δ and 
PCNAa simultaneously. Furthermore, Kctd13 stimulates DNA polymerase δ activity in the 
presence of PCNA. Nuclear localization was shown at replication foci suggesting a 
function in DNA replication239. This is consistent with a function of mec-17 in modulation 
of chromatin structure. Conflicting results on the localization of mec-17 previously 
gathered in our lab could be an artifact of overexpression of the protein or crossreactivity 
of antibodies. However, a function in replication shows no obvious correlation with the 
role in differentiation of neurons observed in C. elegans. 
Psmc5 is known best as part of the 19S regulatory particle of the 26S proteasome. 
Additionally, involvement in transcriptional regulation has been suggested. This is 
consistent with the finding that Psmc5 is localized predominately at the nucleus, in fact, it 
has been shown to be part of the nuclear 26S proteasome. Interaction with several nuclear 
receptors/transcription factors has been demonstrated. Psmc5 could exert its effect on 
                                                
a
 Proliferating cell nuclear antigen 
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transcription by targeting transcription factors for selective degradation by the proteasome 
or by modulating protein-protein interactions in transcriptional complexes240,241. 
Additional evidence comes from the yeast homolog SUG1. It has been shown to display 
helicase activity242 and to enhance the interaction of the SAGA coactivator complex 
(which also harbors the HAT Gcn5) with other transcriptional coactivators and its 
recruitment to promoters243. Recently, direct involvement of Sug1 in regulation of 
transcription of MHC class IIa by controlling promoter association of CIITAb has been 
demonstrated. Together with documented functions of other 19S ATPases, a role in 
regulation of transcription by controlling chromatin modifications seems plausible244. All 
these data are consistent with a role of mec-17 as an acetyltransferase involved in 
transcriptional regulation. Furthermore, Psmc5 has a potential acetylation site at Ala2 
annotated. Thus, it could be a substrate for mec-17 giving an explanation for the failure to 
co-immunoprecipitate with mec-17 despite the interaction demonstrated in the yeast 2-
hybrid screen. 
The interaction of mec-17 with proteins associated with the cytoskeleton as Dctn1, 
Epb4.1l3, Spnb2 as well as Kif2A and 5B is consistent with a neuron-specific function for 
mec17 since the cytoskeleton is of special importance for the function of neurons. 
Consistent with this, in C. e. individuals harboring a mutation in mec-17 show a reduced 
number of cell-specific microtubules in touch receptors236. Dctn1 is part of the dynactin 
complex required for retrograde axonal transport in neurons245. A mutation of Dctn1 at the 
microtubule binding domain is linked to motor neuron degeneration246. Kif5B is involved 
in axonal transport of mitochondria and synaptic vesicle precursors247. For Epb4.1l3, a role 
in the interaction of axons with Schwann cells and maturation of axons and in myelinating 
glial cell-axon interactions has been suggested248. 
Immt (Mitofilin) is an integral membrane protein of the inner mitochondrial membrane249. 
Although it has been shown to be acetylated on a lysine residue250, the interaction of an 
integral membrane protein in a yeast 2-hybrid screen seems questionable. 
Rps27a is expressed as fusion to ubiquitin which is very likely subject to cleavage. Due to 
the architecture of the library plasmid used in the screen, mec-17 is probably interacting 
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 Major histocompatibility complex class II 
b
 Class II transactivator 
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with the ubiquitin, not with Rps27a itself. The reasons for interaction of mec17 with 
ubiquitin could be manifold but it may be linked to the interaction with the proteasomal 
protein Psmc5. 
For mRas, a role in cell survival of neural derived cells has been implicated251. The 
expression of mRas (also known as R-Ras3) is highly restricted to the central nervous 
system, and ectopic expression of the protein was shown to induce neuronal 
differentiation252. 
Summing up, the precise function of mec-17 was not unveiled by the interacting proteins 
found in the screen, but several candidates underscore a role in neuron development and/or 
function, and there are also some hints that mec-17 may indeed be involved in 
transcriptional control and/or regulation of chromatin structure. 
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4 Conclusion 
For the first time, the functionality of prenylation motifs present in bacterial proteins has 
been demonstrated. The C-terminus of variants of an ankyrin repeat protein from different 
strains of Coxiella burnetii becomes farnesylated by the eukaryotic enzyme present in 
rabbit reticulocyte lysate in vitro. Thus, pathogenic bacteria seem to be able in principle to 
utilize the prenyltransferases of their eukaryotic hosts for prenylation of their proteins. 
Furthermore, localization studies in human cells indicated that prenylation of the 
Legionella pneumophila F-Box protein is important for targeting the protein to 
intracellular membrane compartments. Together with the recent result that F-Box is 
secreted into the cytoplasm of macrophages (Hwei Ling Khor et al., 2008, to be 
published), it is highly likely that prenylation of bacterial proteins is not just a freak of 
nature caused by the lack of prenyltransferases and, thus, lack of selection against 
prenylation motifs in bacteria, but a mechanism that might be important in vivo for the 
proper localization and function of secreted proteins. Further studies of other bacterial 
proteins with predicted prenylation sites will be needed to clarify whether this mechanism 
is widely used or just a rare occasion. 
Prenylation motifs display specific sequence requirements needed for functionality, with 
restriction up to a single amino acid at the site of attachment. In the surrounding 
environment, at least a certain pattern of physical properties is needed. Thus, exchange of a 
single residue due to SNPs could influence the efficiency of recognition and modification 
by prenyltransferases. Among several protein candidates with SNPs predicted to influence 
the prenylation motif, prenylation of human ALDH3B2 turned out be significantly 
improved by exchange of W353 with glycine. This example can be viewed as a snapshot 
of evolution as prenylation motifs might be generated or destroyed by the accumulation of 
several mutations over time. Furthermore, SNPs are suggested to be the cause for 
individual differences in susceptibility to diseases and drugs which would be explained 
nicely by an influence on the posttranslational modification status of proteins. Therefore, 
the differential prenylation of the SNP variants of ALDH3B2 represents an exciting 
example for the influence of SNPs. Further investigations will be needed to explore the full 
impact of this observation on biochemistry and medicine. 
Together with other membrane attachment factors, myristoylation is responsible for proper 
targeting and membrane attachment of a manifold array of proteins. One important group 
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consists of proteins involved in asymmetric cell division in neural development. 
Myristoylation of certain asymmetrically localized protein targets is suggested to be 
required for asymmetric distribution to daughter cells after mitosis. The proteins numb-A, 
neur-C, and Par-1 isoform Q from Drosophila melanogaster as well as neuralized-like 1 
and 2 from Mus musculus were shown to be myristoylated in vitro. The impact of the 
modification on subcellular localization was studied in transgenic flies and in mouse cells, 
respectively. Interestingly, all of the fly proteins exist in more than one isoform but only a 
subset of these isoforms is myristoylated. Other N-terminal sequences of numb and Par-1 
miss the obligatory glycine residue while neur-B is not myristoylated, despite the presence 
of an N-terminal glycine, due to other unfavorable residues in the sequence. The 
differential myristoylation of protein isoforms suggests that they might carry out different 
functions or the same function at different locations. These results also underscore the 
importance of distinguishing between isoforms with different potential for 
posttranslational modification in functional studies. 
The human transcription factor NFAT5 is another exciting example of this phenomenon. 
While isoforms B and C do not possess an N-terminal glycine, isoform A is myristoylated 
in vitro. Furthermore, myristoylation was shown to be required to prevent translocation of 
NFAT5-A to the nucleus. Thus, this might be the first case of a transcription factor using a 
new mechanism for regulation of mobilization and nuclear shuttling. While the nuclear 
localization sequence of cytosolic transcription factor proteins is usually masked by 
inhibitor proteins that are removed upon activation, a second class of transcription factors 
has their NLS exposed all the time but is anchored by transmembrane domains and 
released by proteolytic cleavage. A similar mechanism could be utilized by a myristoylated 
transcription factor. Alternatively, reversible palmitoylation could be used as a switch for 
membrane attachment and release. In conclusion, a completely new mechanism is 
suggested for the regulation of localization of NFAT5-A. As the other isoforms are not 
myristoylated, they might exert divergent functions. 
A function as histone acetyltransferase was predicted for mec-17 from Caenorhabditis 
elegans as well as homologous proteins from other species. N-acetyltransferase activity of 
these proteins was successfully demonstrated in our lab. However, histones turned out to 
be a weak substrate. HATs are usually part of multiprotein complexes. The other 
components of these complexes are known to influence activity and substrate specificity of 
the HATs. Furthermore, various non-histone proteins are acetylated by so-called HATs. A 
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yeast 2-hybrid screen was used to identify proteins interacting with mouse mec-17. These 
might be members of a complex or substrates for acetylation. The interaction with Kctd13 
has been verified biochemically by co-immunoprecipitation. Together, the proteins 
identified indicate a function in transcriptional regulation and/or regulation of chromatin 
structure. Furthermore, the suggested role in neuronal development is underscored by the 
results. 
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5 Materials and Methods 
5.1 Buffer Composition 
DNA sample buffer 
50% Glycerol 
1 mM EDTA 
0.25% Bromophenol blue 
0.25% Xylene cyanol FF 
EF-buffer 
12.6 g K2HPO4 
3.6 g KH2PO4 
0.9 g  Na-citrate 
0.18 g MgSO4 
1.8 g (NH4)2SO4 
88 g Glycerol 
for 1 L buffer 
FSB buffer 
10 mM KOAc, pH 6.2 
10 mM KCl 
50 mm CaCl2 
10% Glycerol 
Glutathione elution buffer (GEB) 
50 mM Tris-HCl, pH 8.0 
10 mM reduced glutathione 
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Hunt-buffer 
20 mM Tris-HCl pH 8.0 
100 mM  NaCl 
1 mM EDTA 
0.5% Nonidet P-40 
Lysis buffer A 
20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) pH 7.5 (with acetic 
acid) 
100 mM KOAc 
5 mM  Mg(OAc)2 
0.1% Triton X-100 
One-Step-buffer 
200 mM LiOAc 
100 mM Dithiothreitol (DTT) 
40% PEG 4000 
prepare fresh before use from stock solutions 
P1 
50 mM Tris-HCl pH 8.0 
10 mM EDTA 
0.01% RNase A 
P2 
0.2 M NaOH 
1% Sodium dodecyl sulfate (SDS) 
P3 
3 M KOAc, pH 5.5 
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Phosphate buffered saline (PBS) 
10 mM NaH2PO4/Na2HPO4, pH 7.4 
150 mM NaCl 
PBS-T 
See PBS, + 0.1% Tween 20 
SDS-PAGE running buffer 
30 g Tris base 
144 g Glycine 
10 g SDS 
for 1 L 10-fold buffer 
SDS-PAGE sample buffer 
60 mM Tris-HCl, pH 6.8 
10% Glycerol 
2% SDS 
1% 2-mercaptoethanol 
0.002% Bromophenol blue 
use as 6-fold buffer 
TBE-buffer 
89 mM Tris base/boric acid, pH 8.3 
2 mM EDTA 
TE 
10 mM Tris(hydroxymethyl)aminomethane (Tris)-HCl, pH 7.5 
1 mM Ethylendiaminetetraacetic acid (EDTA) 
TE/LiOAc 
100 mM LiOAc 
in TE 
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TE/PEG/LiOAc 
100 mM LiOAc 
40% PEG 3350 
in TE 
Z-buffer 
60 mM Na2HPO3 
40mM NaH2PO3 
10 mM KCl 
1 mM MgSO4 
(50 mM β-mercaptoethanol) 
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5.2 Composition of media 
bacterial defined minimal medium 
Autoclave 5 times 15 g agar in 800 ml dH2O, cool to 50°C. 
Dissolve 
68.77 g K2HPO4 
22.5 g KH2PO4 
5 g (NH4)2SO4 
2.5 g Na-citrate . 2H2O 
in 800 ml dH2O, autoclave and cool to 50°C, add 50 ml each of URA, HIS and LEU (stock 
(4 mg/ml), 5 ml 1 M MgSO4, 50 ml 20% glucose, 5 ml Kanamycin (stock 10 mg/ml), 0.5 
ml Ampicillin (stock 100 mg/ml) and 2.5 mg thiamin-HCl. 
Mix 200 ml of this solution with 800 ml of the agar solution and pour plates. 
Luria Broth (LB) 
1% Yeast-extract 
1% Trypton 
0.5% NaCl 
0.1% Glucose 
SC-X 
0.67% Yeast nitrogen base (YNB) without amino acids 
2% Glucose (or galactose, with additional 1% raffinose) 
1% 100 x amino acid mix without X 
for plates, add 3 % agar 
SOB 
0.5% Yeast extract 
2% Trypton 
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 
10 mM MgSO4 
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SOC 
See SOB + 20 mM glucose 
SOP-medium 
 Dulbeccos modified eagle medium (DMEM) 
10% Fetal calf serum (FCS) 
1% Penicillin (stock 10.000 units/ml) 
1% Streptomycin (stock 10 mg/ml) 
1% Glutamine (stock 200 mM) 
YPD 
1% Yeast Extract 
2% Pepton 
2% Glucose 
5.2.1 100 x Amino acid stocks 
Adenosine 3 mg/ml Lysine 4 mg/ml 
Uracil 4 mg/ml Phenylalanine 5 mg/ml 
Histidine 2 mg/ml Tyrosine 2 mg/ml 
Methionine 2 mg/ml Isoleucine 2 mg/ml 
Tryptophane 3 mg/ml Valine 6.5 mg/ml 
Threonine 15 mg/ml Arginine 3 mg/ml 
leucine 8 mg/ml Asparagine 10 mg/ml 
 
Do not autoclave Trp and Thr! 
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5.3 cDNA clones 
organism name Protein 
accession 
source 
Coxiella burnetii 
(RSA493) 
Ankyrin repeat 
containing protein, 
CBU_0356 
NP_819396.1 J. E. Samuel 
Coxiella burnetii 
(Dugway 7E9-12) 
Hypothetical 
protein, 
CburD_01001505 
ZP_01298590 J. E. Samuel 
Coxiella burnetii 
(RSA331) 
Hypothetical 
protein, 
CburR_01001221 
ZP_01309761.1 J. E. Samuel 
Coxiella burnetii 
(Graves) 
  J. E. Samuel 
Legionella 
pneumophila 
Hypothetical 
protein lpg2525 
YP_096532.1  
Homo sapiens ALDH3B2 NP_000686.2 IRAUp969B0231D6 
(imaGenes) 
Homo sapiens BEX2 NP_116010.1 IRATp970G1018D6 
(imaGenes) 
Homo sapiens UTP14A NP_006640.2 IRAUp969B0312D6 
(imaGenes) 
Homo sapiens FLJ20364 NP_060255.2 IRAUp969B0653D6 
(imaGenes) 
Drosophila 
melanogaster 
Igloo-L AAB32065.1 RE17162 (DGRC) 
Drosophila 
melanogaster 
Numb-A AAA28730.1 LD45505 (DGRC), 
provided by J. 
Knoblich 
Drosophila 
melanogaster 
Neur-B AAK93411.1 provided by J. 
Knoblich 
Drosophila 
melanogaster 
Neur-C AAO41451.1 RE20876 (DGRC) 
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Drosophila 
melanogaster 
Par-1-Q AAM75016.1 GH14769 (DGRC) 
Mus musculus Neuralized-like 1 AAH58386.1 IRAVp968A02118D6 
(imaGenes) 
Mus musculus Neuralized-like 2 AAK97495.1 Modified from 
neuralized-like 1 by 
PCR 
Mus musculus 2610110G12Rik 
(mec-17 homolog) 
NM_082752 RIKEN cDNA library 
Mus musculus Kctd13 NP_766335 RIKEN cDNA library 
Mus musculus Rps27a NP_077239 RIKEN cDNA library 
Mus musculus Immt NP_083949 RIKEN cDNA library 
Mus musculus mRAS NP_032650 RIKEN cDNA library 
Mus musculus Psmc5 NP_032976 Mouse brain cDNA 
library 
Mus musculus Kif5b NP_032474 IRAVp968G12160D 
(imaGenes) 
Mus musculus Epb4.1l3 NP_038841 Provided by J. 
Conboy 
 
All cDNA clones were checked by sequencing. The cDNAs from Coxiella burnetii were 
kindly provided by James E. Samuel, Department of Microbial and Molecular 
Pathogenesis, College of Medicine, Texas A&M Health Science Center, College Station, 
TX. A mouse brain cDNA library was provided by Egon Ogris, Department of Medical 
Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna. The cDNAs for 
numb-A and neur-B from Drosophila melanogaster were provided by Jürgen A. Knoblich, 
Institute of Molecular Biotechnology. A cDNA encoding Epb4.1l3 was provided by John 
G. Conboy, Life Science Division, Ernest Orlando Lawrence Berkeley Laboratory, CA. 
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5.4 Cloning procedures 
For the in vitro prenylation assay, candidate cDNAs were amplified by PCR with 
appropriate primers (MWG Biotech) including the Stop-Codon. The PCR products were 
cloned into the pGEM-T Easy vector (Promega). Mutations were inserted by site directed 
mutagenesis. The constructs were subcloned into pGEX-5X-1 (Amersham). For 
localization studies, the same constructs were subcloned into pEGFP-C2 (Clontech). 
For the in vitro myristoylation assay, candidate cDNAs were amplified by PCR without 
stop codon with primers adding a T7 promoter and Kozak consensus sequence directly 
prior to the start codon (aagcgtaatacgactcactatagggagaccacc).The PCR products were 
cloned into the pGEM-T Easy vector and subcloned into a self constructed vector for C-
terminal GST-tagging. This vector was created by amplification of GST from the pGEX-
5X-1 vector and insertion downstream of the multiple cloning site of the pSK+ vector 
(Stratagene). For localization studies in HeLa or 3T3 cells, the same constructs were 
subcloned into pEGFP-N3. For generation of transgenic flies, the candidate sequences 
were amplified by PCR without stop codon with primers containing attB recombination 
sequences for Gateway cloning. The PCR products were recombined into pDONR221 and 
subsequently recombined into a Drosophila pUAST gateway destination vector with a C-
terminal myc-tag. 
For the yeast 2-hybrid assay, the cDNA encoding M. m. mec-17 was amplified by PCR 
with appropriate primers including the termination codon, cloned into pGEM-T Easy and 
then subcloned into the bait vector pEG202. 
For immunoprecipitation experiments, M. m. mec-17 including the termination codon was 
subcloned into the pEGFP-N3 vector for expression without tag. The cDNAs for mec-17 
interaction partners from the screen were amplified by PCR including the Stop-Codon and 
cloned via pGEM-T Easy into pENTR4. These constructs were recombined into a 
Gateway destination vector harboring an N-terminal FLAG-HA double tag. 
5.4.1 PCR 
In a standard setup, a total amount of 10 pmol primers and ~20 ng plasmid DNA were 
used per reaction. PCR reactions for cloning were done with 1 µl deoxynucleotide mix 
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(Eppendorf) and 1 µl Pfua Turbo polymerase (Stratagene) in a total reaction volume of 25 
µl. Amplification of DNA for use in coupled in vitro transcription/translation was done 
with PuReTaq Ready-To-Go PCR beads (GE Healthcare). Standard reaction conditions 
were 30 cycles with a denaturing temperature of 94°C, annealing temperature usually 53°C 
(depending on the primer melting temperature), and extension at 72°C for one minute per 
kb product size. For TA-cloning of PCR products generated with Pfu polymerase, 1 µl of 
50 mM MgCl2, 1 µl 10mM ATP, and 1 µl Taqb polymerase were added subsequently and 
incubated for 15 min at 72°C. The samples were checked and purified by agarose gel 
electrophoresis. 
5.4.2 Agarose gel electrophoresis 
For a standard gel 1% agarose (Biozym) in TBE buffer was boiled in the microwave and 
cooled to ~50°C. Prior to pouring, 0.5 µg ethidium bromide per ml was added from a stock 
solution (10 mg/ml). DNA samples were mixed 5:1 with DNA sample buffer, loaded onto 
the gel, and run in TBE buffer at a constant voltage of 100 V. Subsequently, DNA was 
visualized by UV illumination. When agarose gel electrophoresis was used for 
purification, DNA fragments were excised from the gel with a scalpel blade and eluted 
with the QIAquick gel extraction kit (QIAGEN) according to the manual. 
5.4.3 Ligation 
Ligation of PCR-products into pGEM-T Easy (Promega) was done according to the 
manufacturers manual. Ligation of fragments created by restriction digestion was done 
with T4 DNA ligase (Roche) at room temperature (RT) for one hour or at 16°C overnight. 
Ligation products were transformed into chemically competent E. coli (strain DH5α) for 
amplification. 
5.4.4 Transformation into chemically competent bacteria 
Bacteria were inoculated into 3 ml LB-medium and incubated at 37°C overnight with 
shaking. 1 ml of the culture was diluted into 100 ml LB-medium and grown at 37°C to an 
                                                
a
 Pyrococcus furiosus 
b
 Thermophilus aquaticus 
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OD600 (optical density) of 0.5 – 1. Cells were pelleted by centrifugation at 4000 g for 10 
min at 4°C, resuspended in 15 ml FSB buffer, and incubated for 10 min at 4°C. A second 
centrifugation step was followed by resuspension in 4 – 8 ml FSB (depending on the final 
OD). This suspension was used immediately or divided into aliquots and stored at -80°C. 
Frozen aliquots of chemically competent bacteria were thawed on ice. 100 µl were used 
for each transformation. Ligation products (or plasmid in appropriate dilution) were mixed 
with the cells and incubated on ice for 30 min. The cells were heat-shocked at 42°C for 45 
sec and then cooled on ice for 2 min. After addition of 1 ml LB-medium, cells were 
revived for ~ 1 h at 37°C with shaking. Cells were pelleted for 1 min at 13.000 rpm in a 
tabletop centrifuge. Medium was decanted and cells resuspended in the residual medium 
(~100 µl). The whole suspension was plated onto selective agar plates (containing the 
appropriate antibiotic) and incubated upside down at 37°C overnight. For blue/white-
selection (with pGEM-T Easy), 100 µl of 0.1 M Isopropyl-β-D-thiogalactopyranosid 
(IPTG) and 20 µl of 5-Brom-4-chlor-3-indoxyl-β-D-galactopyranosid (X-Gal, 20 mg/ml) 
were plated prior to the cells. 
5.4.5 Plasmid preparation from bacteria (Mini-Prep) 
Single colonies were picked and inoculated into 4 ml of the appropriate selective medium. 
Cells were grown at 37°C overnight. If needed, stocks were prepared by mixing 500 µl of 
culture with 500 µl 2 x EF-buffer and stored at -80°C. 3 ml of culture were pelleted in a 
tabletop centrifuge at 13.000 rpm for 3 min. Plasmid DNA was prepared with the QIAprep 
Spin Miniprep kit (QIAGEN) according to the manufacturers manual. Alternatively, the 
alkaline lysis method was used. Cells were resuspended in 300 µl P1. 300 µl P2 was added 
and mixed by inverting the tube several times. 300 µl P3 were added and mixed again. Cell 
fragments were pelleted for 10 min at 13.000 rpm in a tabletop centrifuge, and the 
supernatant was transferred to a new tube. 650 µl isopropanol was added and incubated for 
10 min at RT. After centrifugation for 10 min at 13.000 rpm, the supernatant was aspired 
and the pellet washed with 70% ethanol, dried in a speedvac, and solubilized in TE. The 
DNA preparation was checked by restriction digestion. 
5.4.6 Restriction digestion 
Usually 2 – 300 ng plasmid DNA was digested with 5 units of one or more restriction 
enzymes (Roche or Fermentas) in a total volume of 15 µl for one hour (reaction conditions 
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like buffer and temperature as suggested for the enzymes by the manufacturer). For 
subcloning, the vector was dephosphorylated with 1 unit shrimp alkaline phosphatase 
(Roche) for 10 min at 37°C. Subsequently, the enzyme was deactivated for 15 min at 
65°C. The digests were analyzed by agarose gel electrophoresis. 
5.4.7 Site directed mutagenesis 
Site directed mutagenesis was done with the QuickChange XL site directed mutagenesis 
kit (Stratagene) according to the manufacturers manual. 
5.4.8 Gateway cloning 
PCR products with attB recombination sites were recombined with a donor vector using 
BP clonase mix (Invitrogen) according to the manual creating an entry vector. 
Alternatively, standard restriction cloning methods were used to clone the ORF of interest 
into an entry vector. Subsequently, the ORF was recombined into a destination vector with 
LR clonase mix (Invitrogen) to create an expression clone. Gateway reaction products 
were transformed into chemically competent E. coli or electroporated into 
electrocompetent E. coli. The E. coli strain DB3.1 was used for maintaining stocks of the 
empty Gateway vectors. 
5.4.9 Transformation of E. coli by electroporation 
Bacteria were inoculated into 5 ml LB-medium and incubated at 37°C overnight with 
shaking. The culture was diluted into 500 ml LB-medium and grown at 37°C to an OD600 
of 0.5. The cells were chilled on ice for 30 min and pelleted by centrifugation at 4000 g for 
10 min at 4°C. Subsequently the pellet was resuspended in 300 ml 10% glycerol and 
pelleted again. The procedure was repeated with 150 ml and 10 ml. Finally, the cells were 
resuspended in 2 ml 10% glycerol, divided into aliquots and stored at -80°C. 
For transformation, electroporation cuvettes were cleaned with soap and then washed with 
dH2O and 70% ethanol. Subsequently, the cuvettes were irradiated for at least one hour 
with UV light. Frozen electrocompetent cells were thawed on ice. 50 µl cells were mixed 
with plasmid DNA on ice and transferred to a clean electroporation cuvette. 
Electroporation with a gene pulser (BioRad) at 1.7 V, 25 µFD and 200 Ω resulted in time 
constants between 3.7 and 4.3. The cells were mixed with 1 ml SOC-Medium, revived for 
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30 min at 37°C with shaking, pelleted by centrifugation and plated onto selective medium. 
The plates were incubated for up to 2 days at 37°C. 
5.5 Biochemical techniques 
5.5.1 Coupled in vitro transcription/translation 
For the N-terminal GST-fusions analyzed regarding their prenylation status, DNA was 
amplified by PCR with puReTaq Ready-To-Go PCR Beads (Amersham Biosciences) 
using a 5’-primer containing a T7-promoter and a Kozak consensus sequence. It anneals at 
the 5’-end of the DNA encoding the GST-tag: 
5’ gcgtaatacgactcactatagggagaccaccatgtcccctatacttaggttattgg 3’ 
The bold region represents the start codon of the GST-tag. The 3’-primer was designed to 
anneal in pGEX-vectors downstream of the insert, allowing the use of the same primer pair 
for all proteins: 
5’ agatcgtcagtcagtcacgat 3’ 
For C-terminal GST fusions analyzed for myristoylation, DNA was amplified by PCR 
using a 5’-primer annealing to the T7 promoter cloned upstream of the start codons: 
5’ gcgtaatacgactcactatagggagaccacc 3’ 
A 3’-primer was designed to anneal downstream of the insert: 
5’ ccctcactaaagggaacaaaagc 3’ 
For analysis of lipid modifications, the radioactive label of choice, that is 20 µCi 
[³H]mevalonate, 10 µCi [³H]FPP, or 10 µCi [³H]GGPP for prenylation or 20 µCi 
[³H]myristic acid for myristoylation (all purchased from American Radiolabeled 
Chemicals), was transferred to Eppendorf  tubes and dried in a speedvac under vacuum at 
room temperature to remove the ethanol which could disrupt the transcription/translation. 
20 µl rabbit reticulocyte lysate, 0.5 µl PCR-Enhancer, and 0.5 µl methionine were added 
which were all supplied with the TNT Quick Coupled Transcription/Translation Kit 
(Promega). For preliminary translation tests, [35S]-methionine (Amersham) was used 
without radioactive lipids. 
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The reaction was started by addition of 2.5 µl of the PCR reaction and incubated at 30 °C 
(4 h for prenylation, 2 h for myristoylation). For purification of the translated protein, 50µl 
glutathione sepharose 4B-beads (75% slurry, Amersham Biosciences) were separately 
resuspended in 0.5 ml PBS and spun down in a microcentrifuge at 1.600 rpm for one 
minute. The supernatant was removed and the washing step repeated once to equilibrate 
the beads for protein binding. The whole TNT reaction-mix and PBS to a final volume of 
200 µl was added. After resuspension, the beads were incubated with gentle agitation at 
room temperature for 1 hour. Afterwards, they were washed 5 times with 0.5 ml PBS. 
Following the last washing step, 50 µl of GEB buffer were added and incubated again for 
1 hour with agitation. The supernatant was removed, mixed with an appropriate volume of 
sample buffer,incubated for 5 min at 95°C, and resolved by SDS-PAGE. For 
myristoylation targets, purification was skipped. Instead, the reaction mix was diluted to a 
total volume of 100 µl with PBS, mixed with an appropriate volume of sample buffer, 
incubated for 15 min at 60°C and resolved by SDS-PAGE. The protein was transferred 
from the gel to a nitrocellulose membrane by electroblotting. The membrane was left to 
dry. Each lane was scanned separately for 20 min using a Berthold TLC linear analyzer LB 
282. Total protein yield was detected by Western Blot with anti-GST antibody (Anti-GST-
HRP-conjugate, Amersham Biosciences, 1:5.000). 
5.5.2 Co-Immunoprecipitation 
A 10 cm dish of N2A cells (~80% confluent) was transiently transfected with the desired 
expression clones. The next day, cells were detached from the dish with trypsin. Medium 
was removed by centrifugation at 500 g for 5 min at 4°C. The cells were washed with 1 ml 
PBS and resuspended in 500 µl Hunt-buffer supplemented with Complete protease 
inhibitor cocktail (Roche). Lysis was achieved by freezing in liquid nitrogen, thawing at 
37°C, and another step with freezing and thawing at RT. Cellular debris was removed by 
centrifugation at 13.000 rpm in a tabletop centrifuge for 10 min at 4°C. The lysate was 
split in two aliquots and 50 µl anti-mec-17 antibody was added to one aliquot. After 
incubation on a rotor at 4°C for 1 h, 50 µl anti-rabbit IgG-beads (100 µl suspension, 
Dynabeads M-280, sheep anti-rabbit IgG, Invitrogen) for each aliquot were equilibrated in 
Hunt-buffer and incubated with the lysate for 1 h at 4°C. The beads were washed three 
times with 500 µl Hunt-buffer, and then protein was eluted by addition of 50 µl 2-fold 
sample buffer and incubation at 95°C for 5 min. Protein was resolved by SDS-PAGE and 
detected by Western Blot. 
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5.5.3 SDS-PAGE 
Separation gel 10% 15% Stacking gel  
H2O 12 8 H2O 6,8 
1M Tris-HCl, pH8.8 7 7 0,5M Tris-HCl, pH6,8 1,25 
AA (30%) 37,5:1 10 15 AA (30%) 37,5:1 1,7 
10% SDS 0,3 0,3 10% SDS 0,1 
TEMED (µl) 25 25 TEMED (µl) 10 
APS 20% (µl) 150 150 APS 20% (µl) 50 
 
The recipes are for eight gels. All volumes are in ml unless otherwise noted. All 
components were mixed according to the recipe adding NNN’N’-
Tetramethylethylenediamine (TEMED) and ammoniumpersulfate (APS) last. Separation 
gel was poured, overlaid with butanol, and left for polymerization at RT for at least 15 
min. Subsequently, butanol was removed and the stacking gel cast. For electrophoresis, 
gels were inserted into a Mini-PROTEAN 3 cell (BioRad) after washing the slots with 
running buffer. Gels were run at a constant current of 30 – 50 mA per gel. 
5.5.4 Western Blot 
Proteins were transferred from the gel to a nitrocellulose membrane by semi-dry 
electroblotting in SDS-PAGE running buffer for 2 h at a constant current of 150 mA. The 
membrane was blocked with 5 % skim milk powder in PBS-T for 1 h at RT with gentle 
agitation. The membrane was rinsed in PBS-T and incubated with primary antibody 
diluted into PBS-T for 1 h at RT or alternatively overnight at 4°C. It was washed three 
times for 10 min in PBS-T. If required, incubation with secondary antibody was done for 1 
h at RT followed by washing. The wet membrane was incubated with ECL plus Western 
Blotting Detection solution and exposed with Hyperfilm ECL (Amersham Biosciences) for 
appropriate time. 
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5.5.5 Protein expression profile of M. m. mec-17 
A ready-to-use mouse mixed tissue Western Blot (Zyagen) was blocked, incubated with 
anti-mec17 antibody (1:1000) as primary antibody and anti-rabbit-HRP-conjugate 
(1:10.000, Amersham) as secondary antibody. Detection was performed as described. 
5.6 Cell culture techniques 
Cells were cultured in SOP-medium in 100 mm dishes at 37°C and 5% CO2. For dilution 
of confluent cells, the medium was aspired and the cells were washed with 10 ml PBS. To 
detach the cells from the dishes, they were incubated with 1 ml 0.05% trypsin (Gibco) for 
5 min at 37°C. Afterwards, they were diluted with 9 ml medium, and an appropriate 
volume was transferred to a new dish. For microscopy, cells were seeded onto cover slips 
placed in 6 well plates. Transfection was done with Lipofectamine Plus (Invitrogen) 
according to the manual. 
5.7 Fluorescence microscopy of GFP-constructs 
Cells were cultured on cover slips and transfected transiently with GFP-fusion constructs. 
The day after transfection, the cells were rinsed in PBS, fixed in PBS containing 2% 
formaldehyde for 15 – 20 min, washed again, and permeabilized with PBS containing 
0.1% Triton X-100 for 10 min. After a last wash with PBS, the cover slides were rinsed in 
dH2O and mounted on microscope slides using Vectashield hard-set mounting medium 
H1500 (Vector Laboratories). Fluorescence microscopy was carried out with an Axioplan 
2 Imaging Microscope (Zeiss). Images were acquired with a Coolsnap HQ camera 
(Photometrics) and analyzed using the software Metamorph 6.2r4 (Universal Imaging 
Corp.). 
MATERIALS AND METHODS  
 95 
5.8 Yeast 2-hybrid screen 
All plasmids needed for the screen were kindly provided by Andreas Hartig: 
• pEG202 (bait vector, N-terminal LexA fusion) 
• pSH18-34 (reporter plasmid, lacZ downstream of LexA-operators) 
• pRFHM-1 (negative control, LexA fusion of fly protein bicoid) 
• pSH17-4 (positive control, LexA fusion of GAL4) 
• pJK101 (test plasmid for repression assay, constitutive promoter in front of LexA-
operators and lacZ) 
All plasmids were checked by restriction digestion. A mouse brain cDNA library cloned 
into the prey vector pJG4-5 was kindly provided by Egon Ogris as well as the yeast strain 
EGY48, the bacterial strain KC8, and LexA antibody. 
5.8.1 Amplification of the cDNA library 
20 ml of chemically competent DH5α were transformed with 20 µg library DNA in 
aliquots of 0.5 ml and plated onto 14 LB-Amp plates (45 x 45 cm). Transformation 
efficiency was checked by plating a serial dilution of an aliquot. After incubation 
overnight at 37°C, transformation efficiency was determined (4 mio. colonies in total, 
library theoretically has 3.6 mio. independent clones). The colonies were scraped into 300 
ml LB-Amp and diluted to 800 ml to give an OD600 of 4.0. The cells were incubated for 3 
h at 37°C and harvested by centrifugation at 6000 g for 15 min. DNA was prepared with a 
total of 16 Maxi-Prep columns (QIAGEN Plasmid Maxi Kit) to yield a total amount of ~4 
mg library DNA. The DNA was checked by restriction digestion. 
5.8.2 Yeast one-step transformation 
Fresh cells are taken from a plate and mixed with 100 µl of one-step buffer as well as 2 µl 
plasmid DNA and 5µl hs-DNA (herring sperm). The mix was incubated at 45°C for 30 
min, plated onto selective medium, and incubated at 30°C for 2 days. 
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5.8.3 β-galactosidase filter assay 
Colonies were picked and streaked onto new plates with selective medium and grown at 
30°C. A nitrocellulose membrane was put onto the plate and softly pressed on the agar to 
transfer the colonies to the membrane. The membrane was frozen in liquid nitrogen to 
break the cells and thawed at RT. Afterwards, the membrane was put on a piece of 
whatman paper soaked in Z-buffer containing 1 mg/ml X-Gal (stock 100 mg/ml in DMF) 
and incubated at 30°C. Color was monitored for 1 h. 
5.8.4 Total protein lysate from yeast 
A preculture was grown at 30°C overnight. 15 ml selective medium were inoculated at an 
OD600 of 0.2 and grown to ~ 0.6. The cells were harvested by centrifugation at 10.000 g for 
5 min. Medium was decanted and the cells resuspended in the residual medium. After 
transfer to screw-cap tubes, they were pelleted, frozen in liquid nitrogen, and thawed at 
RT. Cells were resuspended in 200 µl lysis buffer A, and ~ 200 µl sterile glass beads were 
added. Cells were broken in the Fast-Prep two times for 10 sec at speed 6. The lysate was 
separated from the beads by centrifugation. 
5.8.5 Large scale yeast transformation 
Yeast already containing the bait plasmid was grown in 750 ml selective medium over 
night at 30°C to an OD600 of ~5. The pre-culture was used to inoculate 12.5 L YPD 
medium to an OD of 0.2. The culture was grown at 30°C for ~3.5 h to an OD of 0.6. Cells 
were harvested by centrifugation at 1000 g for 5 min, washed in dH2O, and split into 10 
aliquots. Those were resuspended in 5 ml TE/LiOAc each. Hs-DNA (10 mg/ml) was 
heated for 5 min at 95°C and then cooled on ice. To each aliquot, 5 mg Hs-DNA and 50 µg 
library DNA were added prior to 30 ml of TE/LiOAC/PEG. The mixture was incubated at 
30°C with moderate agitation for 30 min. After addition of 3.5 ml dimethylsulfoxide 
(DMSO) to each aliquot, heat shock was done at 45°C in a water bath for 15 min followed 
by 2 min on ice. The cells were harvested by centrifugation, resuspended in 500 ml YPD, 
and revived at 30°C for 3 h. Cells were pelleted again, resuspended in 32 ml TE, and 
plated onto 16 plates (45 x 45 cm) with galactose medium (to induce expression of the 
library) selective for the plasmids and also lacking Leu to select for interaction of the 
proteins. 
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5.8.6 Plasmid isolation from yeast 
2 ml selective medium were inoculated with one colony and grown at 30°C overnight. 1.5 
ml were pelleted at 13.000 rpm in a tabletop centrifuge. Supernatant was decanted and the 
pellet resuspended in the residual liquid. 200 µl lysis buffer (TE plus 2% Triton X-100, 1% 
SDS, 100 mM NaCl) and 200 µl phenol/chloroform/isoamylalcohol (25:24:1) were added. 
After addition of ~0.3 g acid washed glass beads and vortexing for 2 min, the samples 
were centrifuged at 13.000 rpm for 5 min. 200 µl of the upper phase were transferred to a 
new tube and mixed with 20 µl 3 M NaOAc pH 5.5 and 440 µl 95% ethanol by vortexing. 
DNA was pelleted at 13.000 rpm for 20 min, washed with 200 µl 70% ethanol, dried, and 
resuspended in TE. 
5.8.7 Liquid β-galactosidase assay 
3 independent colonies for each clone were inoculated into 1.5 ml selective medium and 
grown at 30°C overnight. 3 ml medium were inoculated with the overnight culture to give 
an OD600 of 0.1 and grown for ~5 h to give an OD of 0.5 – 0.8. 1.5 ml were pelleted at 
13.000 rpm for 1 min, washed with 1 ml Z-buffer, and resuspended in 300 µl Z-buffer. OD 
was measured again to correct for losses. 100 µl were transferred to a new tube, frozen in 
liquid nitrogen and thawed at 37°C. The procedure was repeated three times. 700 µl of Z-
buffer with β-mercaptoethanol and 160 µl freshly prepared ONPG in Z-buffer (4 mg/ml) 
were added, mixed by inversion, and incubated at 30°C for 30 min (5 min for positive 
control). The reaction was stopped by addition of 400 µl 1 M Na2CO3. Cell debris was 
removed by centrifugation at 13.000 rpm for 10 min and OD420 was measured. β-
galactosidase activity was calculated according to the following formula: 
1000 x OD420/(t x V x OD600 x concentration factor) 
Time is given in min, volume in ml. 
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7 Abbreviations 
A, Ala alanine 
ADP/ATP adenosine diphosphate/adenosine triphosphate 
AnkRep ankyrin repeat 
Bp base pairs 
C, Cys cysteine 
cAMP cyclo-adenosine monophosphate 
cDNA complementary DNA 
C. e. Caenorhabditis elegans 
Ci Curie 
CoA coenzyme A 
D, Asp aspartate 
Da dalton 
DAPI 4′,6-diamidino-2-phenylindol 
DNA deoxyribonucleic acid 
D. m. Drosophila melanogaster 
DMSO dimethylsulfoxide 
DTT dithiothreitol 
E. coli Escherichia coli 
EDTA ethylendiaminetetraacetic acid 
ELISA enzyme-linked immunosorbent assay 
ER endoplasmatic reticulum 
F, Phe phenylalanine 
FPP farnesylpyrophosphate 
FT farnesyltransferase 
G, Gly glycine 
GFP green fluorescent protein 
GGPP geranylgeranylpyrophosphate 
GGT geranlgeranyltransferase 
GPCR G protein coupled receptor 
GPI glycosylphosphatidylinositol 
GST glutathione-S-transferase 
GTP guanosine triphosphate 
H, His histidine 
HA hemagglutinin 
HAT histone acetyltransferase 
HDAC histone deacetylase 
HeLa Henrietta Lacks 
HIV human immunodeficiency virus 
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H. s. Homo sapiens 
I, Ile isoleucine 
IPTG isopropyl-β-D-thiogalactopyranoside 
K, Lys lysine 
L, Leu leucine 
M, Met methionine 
MAF membrane attachment factor 
M. m. Mus musculus 
mRNA messenger RNA 
N, Asn asparagine 
NLS nuclear localization sequence 
NMT N-myristoyltransferase 
OD optical density 
PAT palmitoyl acyltransferase 
PBR polybasic region 
PBS phosphate-buffered saline 
PCR polymerase chain reaction 
Pfu Pyrococcus furiosus 
PTM posttranslational modification 
Q, Gln glutamine 
R, Arg arginine 
RNA ribonucleic acid 
RNAi RNA interference 
RT room temperature 
S, Ser serine 
S. c. Saccharomyces cerevisiae 
SDS sodium dodecylsulfate 
SDS-PAGE sodium dodecylsulfate polyacrylamide gel electrophoresis 
SNP single nucleotide polymorphism 
T, Thr threonine 
Taq Thermophilus aquaticus 
TLC thin layer chromatography 
TNT transcription and translation 
Tris tris(hydroxymethyl)aminomethane 
V, Val valine 
W, Trp tryptophane 
X-Gal 5-bromo-4-chloro-3-indolyl-β-D-galactoside 
Y, Tyr tyrosine 
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